Oral leukoplakia and related diseases, including avohilmo

K11_ORAL_LEUCOPLAC_RELAT_INCLAVO

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Primary healthcare outpatient: ICD-10 K13.2
  • Hospital discharge: ICD-10 K13.2
  • Cause of death: ICD-10 K13.2

3 out of 7 registries used, show all original rules.

3364

4. Check minimum number of events

None

3364

5. Include endpoints

None

3364

6. Filter based on genotype QC (FinnGen only)

3364

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF7

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 18230 9927 8241
Only index persons 17529 9610 7919
Unadjusted period prevalence (%)
Whole population 0.26 0.28 0.23
Only index persons 0.33 0.35 0.30
Median age at first event (years)
Whole population 59.04 60.99 56.74
Only index persons 58.93 60.83 56.62

-FinnGen-

Key figures

All Female Male
Number of individuals 3364 1913 1451
Unadjusted period prevalence (%) 0.65 0.65 0.64
Median age at first event (years) 60.42 60.13 60.80

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
3013
Matched controls
30132
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K13.2
ICD-10 Finland
Leukoplakia and other disturbances of oral epithelium, including tongue
+∞
323.0
316
*
K13.28
ICD-10 Finland
Other leukoplakia or disorder of epithelium of the palate or tongue
+∞
323.0
459
*
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
16.4
323.0
569
422
K13.29
ICD-10 Finland
Indefinite leukoplakia
+∞
323.0
1522
*
EKA10
NOMESCO Finland
Biopsy of cheek
35.4
323.0
614
216
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
57.5
323.0
822
195
K13.20
ICD-10 Finland
Idiopathic leukoplakia
+∞
323.0
589
*
K13.21
ICD-10 Finland
Leukoplakia caused by tobacco
+∞
318.5
300
*
K13.22
ICD-10 Finland
Erythroplakia of oral epithelium, including tongue
+∞
289.3
273
*
SAA03
NOMESCO Finland
Extended examination of mouth
3.9
263.6
1714
7625
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
17.1
249.9
410
274
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.3
199.2
1484
6817
ECA20
NOMESCO Finland
Biopsy of gingiva
29.3
199.2
273
102
SXA10
NOMESCO Finland
Epithel biopsy of mouth
28.5
196.2
271
104
K13.78
ICD-10 Finland
Other change in the oral mucosa
16.4
190.0
316
214
K13.74
ICD-10 Finland
Lichen rubs planus in the mouth
21.7
184.7
277
140
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
7.6
176.0
442
664
SAA02
NOMESCO Finland
Basic examination of mouth
2.9
155.1
2185
14310
SAA01
NOMESCO Finland
Simple examination of mouth
3.0
146.0
2352
16403
SBA00
NOMESCO Finland
Microbiological examinations
10.8
145.2
292
297
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.9
143.1
1187
5504
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
6.4
142.8
406
716
A07AA02
ATC
nystatin; oral
5.5
140.9
455
940
EJB10
NOMESCO Finland
Excision of lesion of apex or body of tongue
51.4
140.7
170
35
L43.8
ICD-10 Finland
Other lichen planus
12.8
139.8
257
217
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
58.2
135.3
160
29
WX110
NOMESCO Finland
Local anesthesy
2.7
129.7
2297
16218
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.5
123.4
1517
8639
EHA10
NOMESCO Finland
Biopsy of palate
21.2
97.4
146
72
L43.9
ICD-10 Finland
Lichen planus, unspecified
9.4
96.5
207
234
SAA04
NOMESCO Finland
Special inverstigation of mouth
4.9
95.5
336
749
K02.1
ICD-10 Finland
Caries of dentine
2.2
95.4
1836
12392
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
2.3
95.3
1293
7413
SFA10
NOMESCO Finland
Fillning on one surface of tooth
2.1
84.3
1723
11646
EB1AA
NOMESCO Finland
Tooth X-ray examination
2.1
84.1
1803
12431
Z01.2
ICD-10 Finland
Dental examination
2.1
81.7
1356
8338
D20
ICPC
Mouth/tongue/lip symptom/complaint
5.0
77.4
267
578
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
2.0
74.5
1794
12668
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
2.3
73.2
837
4290
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
2.0
73.2
1471
9640
K05.31
ICD-10 Finland
Periodontitis pronounced
3.0
71.1
460
1697
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.9
69.2
477
1833
WZA90
NOMESCO Finland
Other doctors statement
2.3
69.0
820
4257
SXC03
NOMESCO Finland
Other oral or dental procedure
11.2
68.5
133
124
8070/3-C02.1
ICD-O-3
Squamous cell carcinoma, NOS, of border of tongue
55.4
68.3
81
15
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
2.0
68.2
1349
8695
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
2.0
68.2
1535
10402
K13.24
ICD-10 Finland
Gum problems in smokers
+∞
64.8
62
*
TEA00
NOMESCO Finland
Biopsy of lip
12.6
64.1
117
96
B37.08
ICD-10 Finland
Other candidal stomatitis
15.6
62.4
104
69
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
2.1
60.6
844
4658
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
60.3
1443
9829
A01AB09
ATC
miconazole; local oral
2.9
58.9
393
1468
SDA02
NOMESCO Finland
Parodonthologic therapy
2.0
58.7
1068
6555
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
3.5
58.3
294
900
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
2.2
57.4
679
3473
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
7.9
54.1
127
166
K03.64
ICD-10 Finland
Dental calculus supragingival
2.0
51.9
861
5046
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.8
50.1
1353
9389
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
2.0
49.4
831
4880
D82
ICPC
Teeth/gum disease
1.9
49.2
1050
6721
Z2221
NOMESCO Finland
Medical doctor
1.9
48.2
903
5507
EMAK
NOMESCO Finland
NA
4.3
47.8
185
448
EBA00
NOMESCO Finland
Extraction of tooth
1.8
46.9
1024
6579
WX290
NOMESCO Finland
Other blockade of nerve
1.8
46.7
1260
8674
C03.1
ICD-10 Finland
Malignant neoplasm: Lower gum
42.1
46.7
58
14
J02AC01
ATC
fluconazole; systemic
1.8
45.9
1197
8138
KMAK
NOMESCO Finland
NA
1.7
45.5
1522
11167
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
15.7
45.4
75
49
EJB30
NOMESCO Finland
Excision of lesion of floor of mouth
58.7
44.4
52
9
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
15.8
43.2
71
46
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.1
41.8
246
839
D07AC01
ATC
betamethasone; topical
1.8
41.8
1055
7039
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
4.2
41.2
162
398
K05.30
ICD-10 Finland
Periodontitis complex
2.2
41.0
453
2207
D07AD01
ATC
clobetasol; topical
2.1
40.6
543
2880
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.9
40.6
771
4673
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
12.0
40.5
75
64
SBB10
NOMESCO Finland
Teeth copy
3.2
40.2
226
744
D19
ICPC
Teeth/gum symptom/complaint
1.8
38.9
776
4772
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.8
38.7
791
4904
EJ2S1
NOMESCO Finland
Photography of oral mucosa
24.9
38.4
54
22
EKB00
NOMESCO Finland
Excision of lesion of cheek
16.2
38.2
62
39
8070/3-C02.9
ICD-O-3
Squamous cell carcinoma, NOS, of tongue, NOS
85.2
37.9
42
5
K02.0
ICD-10 Finland
Caries limited to enamel
2.3
37.7
398
1894
J01DB01
ATC
cefalexin; oral
1.8
37.6
2415
20848
EJB40
NOMESCO Finland
Hemiglossectomy
55.8
37.4
44
8
K13.6
ICD-10 Finland
Irritative hyperplasia of oral mucosa
9.6
37.2
77
82
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.8
37.1
819
5193
L43.0
ICD-10 Finland
Hypertrophic lichen planus
11.0
36.9
71
66
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.9
36.5
679
4063
A01AB04
ATC
amphotericin B; local oral
3.1
36.4
210
706
A01AC01
ATC
triamcinolone; local oral
5.3
36.2
113
218
C02.10
ICD-10 Finland
Malignant neoplasm of tip of tongue
124.8
34.7
37
*
C06.0
ICD-10 Finland
Malignant neoplasm: Cheek mucosa
65.7
34.0
39
6
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
2.3
33.0
330
1523
-1
NOMESCO Finland
NA
1.7
32.8
923
6253
K13.1
ICD-10 Finland
Cheek and lip biting
13.9
32.5
56
41
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.6
32.3
248
998
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
8.6
31.9
70
83
L43
ICD-10 Finland
Lichen planus
7.1
31.7
79
114
Z3226
NOMESCO Finland
Physiotherapist
1.8
31.4
588
3505
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.8
31.3
581
3448
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
31.3
890
6032
SXC05
NOMESCO Finland
Other oral or dental procedure
3.0
31.0
193
680
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.7
31.0
733
4704
GBB00
NOMESCO Finland
Tracheostomy
6.8
30.8
79
119
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
6.2
30.4
83
136
C04.0
ICD-10 Finland
Malignant neoplasm: Anterior floor of mouth
32.9
30.0
39
12
A02BC02
ATC
pantoprazole; systemic
1.6
30.0
1925
15964
N02AX02
ATC
tramadol; systemic, rectal
1.6
29.8
1256
9404
EB1WA
NOMESCO Finland
NA
10.2
29.6
59
59
N05AH04
ATC
quetiapine; oral
1.9
29.0
467
2629
K12.18
ICD-10 Finland
Other forms of stomatitis
9.1
28.9
61
68
WX002
NOMESCO Finland
Sedation and analgesia
1.8
28.8
617
3825
EDB00
NOMESCO Finland
Partial excision of mandible
21.3
28.7
42
20
N07BA03
ATC
varenicline; oral
2.8
28.6
189
693
JDB10
NOMESCO Finland
Percutaneous gastrostomy
5.8
28.2
81
142
EBA10
NOMESCO Finland
Surgical removal of tooth
2.2
28.1
321
1574
EAA10
NOMESCO Finland
Excision of lesion of lip
6.5
27.3
72
113
VALMI
NOMESCO Finland
NA
1.7
27.3
680
4408
K14.61
ICD-10 Finland
Glossodynia
8.1
26.9
61
77
R4110
NOMESCO Finland
Physiotherapy
1.6
26.6
806
5512
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
2.3
26.4
254
1148
K03.66
ICD-10 Finland
Tooth plaque
2.5
26.1
216
902
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.1
26.0
312
1559
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
26.0
800
5486
ECA30
NOMESCO Finland
Excision of lesion of gingiva
6.8
25.5
65
98
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
25.0
970
7040
B37.03
ICD-10 Finland
Chronic atrophic candida infection in the mouth
14.8
24.7
41
28
N02BE01
ATC
paracetamol; systemic, rectal
1.7
24.5
2521
22746
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
5.6
24.4
72
131
Z2446
NOMESCO Finland
Social worker
2.5
24.4
203
853
ZXD10
NOMESCO Finland
Scheduled procedure
1.5
24.1
1121
8461
K14.9
ICD-10 Finland
Disease of tongue, unspecified
15.8
24.1
39
25
SFA00
NOMESCO Finland
Small filling
1.9
24.1
388
2175
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
2.1
23.8
297
1509
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
2.5
23.8
192
791
C02.2
ICD-10 Finland
Malignant neoplasm: Ventral surface of tongue
87.4
23.7
26
*
Z72.0
ICD-10 Finland
Tobacco use
3.7
23.3
104
288
K12.10
ICD-10 Finland
Stomatitis NOS
9.7
23.2
47
49
C03.0
ICD-10 Finland
Malignant neoplasm: Upper gum
28.4
23.1
31
11
K13.23
ICD-10 Finland
Leukokeratosis nicotina palati
+∞
22.9
22
*
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
22.9
371
2081
8070/3-C06.0
ICD-O-3
Squamous cell carcinoma, NOS, of cheeck mucosa
84.1
22.7
25
*
M79.6
ICD-10 Finland
Pain in limb
1.5
22.6
1015
7570
SDE04
NOMESCO Finland
Periodontal treatment by dental hygienist, very extensive
2.0
22.6
310
1635
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
3.3
22.4
117
367
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
22.4
1312
10353
B37.02
ICD-10 Finland
Chronic hyperplastic candidal stomatitis
32.5
22.4
29
9
E0000UV
ATC
NA
1.5
22.3
1074
8132
Z3231
NOMESCO Finland
Registered nurse
1.6
22.0
779
5490
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.7
22.0
497
3107
J01FF01
ATC
clindamycin; systemic
1.6
21.6
779
5511
8070/3-C04.9
ICD-O-3
Squamous cell carcinoma, NOS, of floor of mouth, NOS
43.6
21.4
26
6
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.3
21.4
213
977
N03AX16
ATC
pregabalin; oral
1.6
21.4
696
4802
J01CE02
ATC
phenoxymethylpenicillin; oral
1.5
20.9
1885
16120
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.9
20.9
351
1991
J01DA01
ATC
[U] cefalexin; systemic
1.4
20.8
1751
14761
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
20.8
472
2952
N05CF01
ATC
zopiclone; oral
1.5
20.8
913
6747
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
7.9
20.7
47
60
R03AC02
ATC
salbutamol; inhalant
1.4
20.7
1445
11743
M25.5
ICD-10 Finland
Pain in joint
1.5
20.7
788
5641
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
20.5
595
3979
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
20.4
708
4954
L17
ICPC
Foot/toe symptom/complaint
1.6
20.4
712
4990
K12.00
ICD-10 Finland
Recurrent oral aphthae
4.8
20.3
68
144
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
2.5
20.2
162
668
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
7.8
20.0
46
60
SBA10
NOMESCO Finland
Measurement of excretion of saliva
6.3
20.0
53
85
H02AB06
ATC
prednisolone; systemic
1.4
20.0
1315
10540
EJW99
NOMESCO Finland
Other operation on tongue or floor of mouth
57.9
19.9
23
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
19.9
443
2752
A02BC05
ATC
esomeprazole; systemic
1.5
19.9
1152
9003
K13
ICD-10 Finland
Other diseases of lip and oral mucosa
14.5
19.8
33
23
S29
ICPC
Skin symptom/complaint other
1.7
19.7
480
3060
K05.1
ICD-10 Finland
Chronic gingivitis
2.2
19.7
212
1010
J01CA04
ATC
amoxicillin; systemic
1.5
19.6
2250
20041
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
19.5
575
3857
ZXA05
NOMESCO Finland
Left side
1.5
19.5
747
5342
K08.2
ICD-10 Finland
Atrophy of edentulous alveolar ridge
5.2
19.4
60
117
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
2.1
19.3
223
1097
K11.70
ICD-10 Finland
Hypoptyalism
7.8
19.3
44
57
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.0
19.2
268
1421
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
2.4
19.1
169
733
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.6
19.0
138
538
N05BA01
ATC
diazepam; systemic, rectal
1.7
18.9
397
2420
UJF32
NOMESCO Finland
Coloscopy
1.5
18.9
735
5270
K13.03
ICD-10 Finland
Keilit UNS
17.2
18.7
29
17
N06AX21
ATC
duloxetine; oral
1.9
18.7
308
1737
N06AX11
ATC
mirtazapine; oral
1.5
18.6
892
6685
ZXC10
NOMESCO Finland
Use of laser
3.4
18.5
91
274
L03
ICPC
Low back symptom/complaint
1.5
18.5
654
4581
S01.50
ICD-10 Finland
Open wound in oral cavity
6.3
18.5
49
79
XQ802
NOMESCO Finland
Epicutan test
2.7
18.5
130
498
Z3229
NOMESCO Finland
Other healthcare associate professional
2.0
18.4
256
1354
N05CD07
ATC
temazepam; oral
1.7
18.2
370
2232
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.9
18.2
274
1494
N05BA04
ATC
oxazepam; oral
1.5
18.0
685
4875
M54.5
ICD-10 Finland
Low back pain
1.5
18.0
890
6701
N06AB04
ATC
citalopram; systemic
1.6
18.0
612
4242
ZXE00
NOMESCO Finland
One hour or less
1.4
18.0
1082
8466
EJB99
NOMESCO Finland
Other excision on tongue and floor of mouth
52.8
17.9
21
*
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.1
17.9
217
1087
P01AB01
ATC
metronidazole; oral, rectal
1.4
17.8
1076
8426
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
2.0
17.7
249
1323
SGA01
NOMESCO Finland
Tooth opening as first aid
1.7
17.5
402
2513
H02AB07
ATC
prednisone; oral
1.7
17.5
406
2545
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
3.1
17.5
97
320
SPF30
NOMESCO Finland
Soling for prothesis
3.6
17.4
80
229
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.5
17.4
137
560
J01MA02
ATC
ciprofloxacin; systemic
1.4
17.3
1056
8271
L28
ICPC
Limited function/disability (L)
1.6
17.1
447
2894
D07AB02
ATC
hydrocortisone butyrate; topical
1.5
17.1
746
5464
E000001
ATC
NA
1.6
17.0
529
3580
R06AE07
ATC
cetirizine; oral
1.4
17.0
1155
9224
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.5
16.8
632
4475
SGA04
NOMESCO Finland
Very demanding opening and dilatation of root canal of tooth
1.9
16.8
276
1554
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.0
16.7
229
1206
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
16.7
1013
7913
R74
ICPC
Upper respiratory infection acute
1.5
16.6
663
4757
S02.51
ICD-10 Finland
Fracture of tooth, open
1.8
16.6
283
1610
L01
ICPC
Neck symptom/complaint
1.7
16.5
370
2297
R13
ICD-10 Finland
Dysphagia
2.1
16.4
198
992
K05.18
ICD-10 Finland
Chronic gingivitis
2.3
16.3
151
670
S18
ICPC
Laceration/cut
1.4
16.3
1147
9193
WX110
SPAT
NA
2.4
16.3
137
581
A02BA02
ATC
ranitidine; systemic
1.5
16.2
559
3876
D10.19
ICD-10 Finland
Benign tumor of the tongue UNS
9.3
16.1
33
36
Z01.9
ICD-10 Finland
Special examination, unspecified
2.2
16.0
174
831
R01AD08
ATC
fluticasone; nasal
1.5
16.0
747
5534
B37.01
ICD-10 Finland
Acute athrophy candidal stomatitis
13.6
16.0
27
20
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
15.9
938
7272
EBB10
NOMESCO Finland
Insertion of dental implant
3.8
15.8
66
175
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
4.1
15.8
61
151
SXA20
NOMESCO Finland
Local application of medicine to mouth
2.2
15.7
157
723
B37.00
ICD-10 Finland
Acute pseudomembraneuous candidal stomatitis
13.0
15.6
27
21
R01AD09
ATC
mometasone; nasal
1.4
15.5
1171
9477
C04.1
ICD-10 Finland
Malignant neoplasm: Lateral floor of mouth
38.2
15.4
19
5
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
1.7
15.4
332
2037
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
4.9
15.2
49
101
L43.3
ICD-10 Finland
Subacute (active) lichen planus
9.8
15.2
30
31
B37.0
ICD-10 Finland
Candidal stomatitis
4.8
14.9
49
103
SPF10
NOMESCO Finland
Demanding repatation of teeth prosthesis
3.2
14.9
79
253
R02
ICPC
Shortness of breath/dyspnoea
1.7
14.9
334
2071
N02AA05
ATC
oxycodone; systemic
1.6
14.9
400
2604
ZXA00
NOMESCO Finland
Right side
1.4
14.7
763
5753
EHB00
NOMESCO Finland
Excision of lesion of palate
10.5
14.7
28
27
J01AA02
ATC
doxycycline; systemic
1.4
14.7
2211
19987
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.8
14.7
272
1592
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.1
14.7
162
781
L08
ICPC
Shoulder symptom/complaint
1.5
14.6
524
3663
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
14.4
1344
11219
M03BX02
ATC
tizanidine; oral
1.4
14.4
1692
14651
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
3.5
14.4
67
195
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.5
14.4
466
3180
N03AX12
ATC
gabapentin; oral
1.6
14.4
423
2821
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
1.7
14.3
322
1995
L43.1
ICD-10 Finland
Bullous lichen planus
17.0
14.3
22
13
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.4
14.2
124
536
EEB00
NOMESCO Finland
Partial excision of maxilla
22.4
14.2
20
9
K04.1
ICD-10 Finland
Necrosis of pulp
1.8
14.1
269
1587
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.5
14.1
107
430
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
14.1
572
4101
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
9.4
13.9
28
30
K03.00
ICD-10 Finland
Approximal wear
2.2
13.9
147
694
C02.9
ICD-10 Finland
Malignant neoplasm: Tongue, unspecified
30.2
13.9
18
6
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.5
13.9
108
438
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.5
13.8
625
4581
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
13.7
557
3990
K08.3
ICD-10 Finland
Retained dental root
1.9
13.7
207
1128
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.3
13.6
127
567
8070/3-C06.9
ICD-O-3
Squamous cell carcinoma, NOS, of mouth, NOS
75.5
13.6
15
*
N06AX16
ATC
venlafaxine; oral
1.6
13.6
352
2269
P17
ICPC
Tobacco abuse
3.8
13.6
57
153
C04.9
ICD-10 Finland
Malignant neoplasm: Floor of mouth, unspecified
+∞
13.5
13
*
XQ800
NOMESCO Finland
Prick test
2.0
13.5
184
966
A02BC01
ATC
omeprazole; systemic
1.4
13.5
747
5690
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.6
13.5
337
2150
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
13.5
268
1604
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
1.8
13.4
256
1512
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
3.0
13.4
78
267
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
5.6
13.4
38
68
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
13.4
487
3407
R01AD11
ATC
triamcinolone; nasal
1.8
13.3
244
1420
SPA20
NOMESCO Finland
Selection and insertion of implantdistans
7.3
13.2
31
43
K13.7
ICD-10 Finland
Other and unspecified lesions of oral mucosa
10.5
13.2
25
24
H01
ICPC
Ear pain/earache
1.8
13.2
252
1490
R51.80
ICD-10 Finland
Headache
1.6
13.2
360
2353
K07.60
ICD-10 Finland
Snapping jaw
2.3
13.1
121
537
EKC00
NOMESCO Finland
Suture of cheek
15.1
13.1
21
14
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.9
13.1
181
959
UJH02
NOMESCO Finland
Anoscopy
2.2
13.0
127
581
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.7
12.9
296
1844
J37.0
ICD-10 Finland
Chronic laryngitis
2.5
12.9
100
407
L15
ICPC
Knee symptom/complaint
1.5
12.9
557
4039
K14.1
ICD-10 Finland
Geographic tongue
6.1
12.8
34
56
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
12.8
984
7916
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
12.8
403
2725
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
4.9
12.8
41
85
M79.1
ICD-10 Finland
Myalgia
1.6
12.7
314
1997
R07.0
ICD-10 Finland
Pain in throat
2.1
12.7
152
759
D10.12
ICD-10 Finland
Bone tumor of the tip of the tongue
15.5
12.6
20
13
L28.0
ICD-10 Finland
Lichen simplex chronicus
4.3
12.6
46
109
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
12.6
283
1755
M01AE01
ATC
ibuprofen; systemic, rectal
1.4
12.6
2538
23707
P01
ICPC
Feeling anxious/nervous/tense
1.9
12.5
201
1119
L12
ICPC
Hand/finger symptom/complaint
1.6
12.3
363
2414
ECB00
NOMESCO Finland
Suture of gingiva
2.4
12.3
106
457
R52.9
ICD-10 Finland
Pain, unspecified
1.8
12.3
230
1347
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
12.3
451
3157
A98
ICPC
Health maint/preventive medicine
1.7
12.3
2815
26945
N06AB10
ATC
escitalopram; oral
1.5
12.3
478
3386
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.4
12.3
586
4330
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
4.4
12.3
43
98
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
4.2
12.3
46
112
P03
ICPC
Feeling depressed
1.9
12.3
192
1064
SPD05
NOMESCO Finland
Demanding fitting of total teeth prosthesis
7.4
12.2
28
38
K03.0
ICD-10 Finland
Excessive attrition of teeth
2.6
12.2
88
345
SFC92
NOMESCO Finland
Other demanding adjuvant procedure of filling therapy
1.9
12.2
189
1043
A06AD11
ATC
lactulose; oral
1.6
12.1
374
2516
N07BB01
ATC
disulfiram; oral
2.2
12.1
123
574
SPA02
NOMESCO Finland
Preparation for dental prosthetics
2.8
12.0
75
269
N03AX09
ATC
lamotrigine; oral
2.2
12.0
115
522
J01FA06
ATC
roxithromycin; oral
1.3
12.0
1081
8893
A04
ICPC
Weakness/tiredness general
1.6
12.0
319
2067
J01MA12
ATC
levofloxacin; systemic
1.5
12.0
490
3508
ZXD05
NOMESCO Finland
Urgent procedure
1.4
12.0
771
6012
SPF20
NOMESCO Finland
Temporary soling for filling
4.1
11.9
45
111
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
11.8
310
2002
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.6
11.8
291
1847
D07AC13
ATC
mometasone; topical
1.4
11.8
748
5814
SDA05
NOMESCO Finland
Very demanding and lengthy parodonthologic therapy
2.0
11.8
146
742
Z97.2
ICD-10 Finland
Presence of dental prosthetic device (complete)(partial)
2.5
11.8
89
358
R68.2
ICD-10 Finland
Dry mouth, unspecified
5.9
11.8
32
55
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.7
11.7
263
1626
M54.4
ICD-10 Finland
Lumbago with sciatica
1.5
11.7
419
2917
EBB15
NOMESCO Finland
Insertion of dental implant abutment
4.2
11.7
43
103
SGC00
NOMESCO Finland
Local medication of root channels of tooth
1.7
11.7
269
1676
SDA12
NOMESCO Finland
Treatment of complicated periodontal disease
3.5
11.7
54
158
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
11.7
417
2902
K14.60
ICD-10 Finland
Glossopyrosis
6.0
11.6
31
52
H04.10
ICD-10 Finland
Dry eye syndrome
1.7
11.6
262
1624
D07AB08
ATC
desonide; topical
1.7
11.6
262
1624
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
3.1
11.6
62
202
C02.1
ICD-10 Finland
Malignant neoplasm: Border of tongue
65.2
11.6
13
*
L02
ICPC
Back symptom/complaint
1.7
11.6
225
1335
N05AA02
ATC
levomepromazine; systemic
2.2
11.6
119
559
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
11.6
1096
9074
S21
ICPC
Skin texture symptom/complaint
1.6
11.6
325
2137
130
Kela drug reimbursment
Malignant tumour
1.7
11.5
223
1320
SGB30
NOMESCO Finland
Other demanding filling of root channel of tooth
1.7
11.5
255
1574
D11
ICPC
Diarrhoea
1.7
11.5
248
1515
K14.69
ICD-10 Finland
Tongue pain UNS
7.2
11.5
27
38
D01
ICPC
Abdominal pain/cramps general
1.7
11.5
253
1560
RS316
NOMESCO Finland
NA
9.3
11.5
23
25
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
1.8
11.4
203
1171
J01FA10
ATC
azithromycin; systemic
1.3
11.4
1485
12853
K06.22
ICD-10 Finland
Functional keratosis of the gingiva
120.4
11.4
12
*
EJC99
NOMESCO Finland
Other reconstructive operations on tongue and floor of mouth
120.4
11.4
12
*
K10.26
ICD-10 Finland
Periostitis of jaw (acute)(chronic)(suppurative)
120.4
11.4
12
*
N05AH03
ATC
olanzapine; systemic
2.0
11.4
143
729
P01BA02
ATC
hydroxychloroquine; oral
1.7
11.4
232
1400
ZXE90
NOMESCO Finland
More than 22 hours
5.0
11.4
35
70
K14.09
ICD-10 Finland
Glossit UNS
15.1
11.3
18
12
ZXE20
NOMESCO Finland
More than three and less than five hours
1.5
11.3
376
2573
Z46.3
ICD-10 Finland
Fitting and adjustment of dental prosthetic device
3.4
11.2
54
163
Z71.8
ICD-10 Finland
Other specified counselling
1.4
11.2
577
4314
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
11.2
714
5548
R53
ICD-10 Finland
Malaise and fatigue
1.4
11.2
496
3607
F45.8
ICD-10 Finland
Other somatoform disorders
2.0
11.2
149
777
A02BC03
ATC
lansoprazole; oral
1.4
11.1
784
6195
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.5
11.1
82
328
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
9.2
11.0
22
24
R21
ICPC
Throat symptom/complaint
1.5
11.0
417
2937
SGA03
NOMESCO Finland
Demanding opening and dilatation of root canal of tooth
1.7
11.0
228
1382
H02AB04
ATC
methylprednisolone; systemic
1.5
10.9
379
2618
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
5.3
10.9
32
61
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.7
10.9
225
1360
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.6
10.8
283
1827
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.7
10.8
215
1287
L43.2
ICD-10 Finland
Lichenoid drug reaction
15.5
10.8
17
11
K02.2
ICD-10 Finland
Caries of cementum
2.1
10.8
127
630
AA1AD
NOMESCO Finland
CT of head and brain
1.4
10.8
631
4829
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
4.6
10.8
36
79
8070/3-C03.1
ICD-O-3
Squamous cell carcinoma, NOS, of lower gum
17.9
10.7
16
9
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
3.2
10.7
55
175
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.5
10.7
329
2208
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
10.7
457
3297
F10.25
ICD-10 Finland
Alcohol dependence continuous use
3.1
10.7
58
192
R05
ICPC
Cough
1.4
10.7
548
4096
SPAT1240
SPAT
Therapeutic discussion
1.7
10.7
237
1465
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.8
10.7
191
1108
EJC00
NOMESCO Finland
Suture of tongue or floor of mouth
60.2
10.6
12
*
R03BB04
ATC
tiotropium bromide; inhalant
1.6
10.6
263
1673
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
10.6
977
8029
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.8
10.5
193
1124
C05AA08
ATC
fluocortolone; rectal, topical
1.5
10.5
381
2654
XF612
NOMESCO Finland
Measurement of central venous pressure
8.5
10.5
22
26
X58
ICD-10 Finland
Exposure to other specified factors
1.5
10.5
334
2260
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
1.8
10.4
189
1100
M01AH05
ATC
etoricoxib; oral
1.3
10.4
1583
13922
8070/3-C03.0
ICD-O-3
Squamous cell carcinoma, NOS, of upper Gum
+∞
10.4
10
*
K05.3
ICD-10 Finland
Chronic periodontitis
1.9
10.4
149
798
N06AB03
ATC
fluoxetine; oral
1.5
10.4
324
2182
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
10.4
415
2951
A01
ICPC
Pain general/multiple sites
1.7
10.4
202
1199
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
10.4
479
3510
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.0
10.3
130
663
SPE01
NOMESCO Finland
Mucosa-supported partial denture
3.3
10.3
51
158
SCA03
NOMESCO Finland
Preventive oral health care, extensive
2.1
10.3
110
526
EJB20
NOMESCO Finland
Excision of lesion of base of tongue
18.8
10.2
15
8
K04.08
ICD-10 Finland
Other specified pulpit
2.0
10.2
136
711
EJB60
NOMESCO Finland
Partial excision of floor of mouth
23.4
10.2
14
6
N05AN01
ATC
lithium; oral
2.7
10.2
68
254
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
10.2
772
6151
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.7
10.2
202
1206
ZY010
NOMESCO Finland
Hospital outpatient
2.2
10.2
104
488
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.1
10.2
120
597
D07BC01
ATC
betamethasone and antiseptics; topical
1.5
10.2
307
2055
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
13.1
10.1
17
13
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.3
10.1
94
424
A46
ICD-10 Finland
Erysipelas
1.5
10.1
359
2492
WX320
NOMESCO Finland
Spinalanesthesy
1.4
10.0
594
4548
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
10.0
474
3484
EBA30
NOMESCO Finland
Excision of root of tooth
1.9
10.0
144
775
ECB20
NOMESCO Finland
Oral alveoplasty
3.9
10.0
39
100
EJ2S1
SPAT
NA
40.2
10.0
12
*
B01AB05
ATC
enoxaparin; parenteral
1.3
10.0
810
6524
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.4
9.9
654
5096
M48.0
ICD-10 Finland
Spinal stenosis
1.5
9.9
323
2201
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
2.4
9.9
78
324
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.3
9.9
89
394
EEA10
NOMESCO Finland
Biopsy of maxilla
16.7
9.9
15
9
M03BC51
ATC
orphenadrine, combinations; systemic
1.3
9.8
710
5616
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
3.5
9.8
44
127
EKA00
NOMESCO Finland
Incision of cheek
26.1
9.8
13
5
D83
ICPC
Mouth/tongue/lip disease
5.9
9.8
26
44
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
9.8
379
2675
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.5
9.8
301
2020
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
10.6
9.8
18
17
A01AB10
ATC
natamycin; local oral
2.4
9.7
79
330
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
3.2
9.7
50
160
SPF40
NOMESCO Finland
Removal and reattachment with cement of tooth crone or short bridge
2.6
9.7
67
259
WKPAL
NOMESCO Finland
NA
2.7
9.7
63
235
R4190
NOMESCO Finland
Nutritional therapy
2.4
9.6
81
346
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.8
9.5
163
931
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.9
9.5
148
818
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.4
9.5
448
3288
Z75.1
ICD-10 Finland
Person awaiting admission to adequate facility elsewhere
3.3
9.5
45
136
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.7
9.5
192
1156
SCF03
NOMESCO Finland
Preventive oral care by dental hygienist, extensive
3.2
9.5
47
147
H03AA01
ATC
levothyroxine sodium; systemic
1.4
9.4
606
4698
L86
ICPC
Back syndrome with radiating pain
1.8
9.4
151
845
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.6
9.4
272
1799
WF003
NOMESCO Finland
Adjuvant radiotherapy
2.1
9.4
104
507
C02.0
ICD-10 Finland
Malignant neoplasm: Dorsal surface of tongue
+∞
9.4
9
*
C09.1
ICD-10 Finland
Malignant neoplasm: Tonsillar pillar (anterior)(posterior)
+∞
9.4
9
*
SAALT
NOMESCO Finland
NA
4.2
9.3
34
82
M03BC01
ATC
orphenadrine (citrate); systemic
1.4
9.3
576
4438
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.7
9.3
207
1282
ECA35
NOMESCO Finland
Complicated excision of lesion of gingiva
7.3
9.2
21
29
EB1AD
NOMESCO Finland
Cone beam CT of teeth and jaws (one quarter)
6.0
9.2
24
40
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
6.0
9.2
24
40
P06
ICPC
Sleep disturbance
1.6
9.2
231
1476
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.7
9.1
199
1224
D07AA02
ATC
hydrocortisone; topical
1.5
9.1
301
2053
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
9.1
752
6053
EB1AA
SPAT
NA
2.0
9.1
119
621
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.1
9.1
97
467
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.5
9.1
355
2514
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.5
9.1
277
1859
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.5
9.0
367
2615
C07AA05
ATC
propranolol; systemic
1.4
9.0
466
3479
N05CF02
ATC
zolpidem; oral
1.4
9.0
440
3250
D10.39
ICD-10 Finland
Benign tumor in other or unspecified part of oral cavity UNS
7.0
9.0
21
30
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.5
8.9
320
2221
A97
ICPC
No disease
1.5
8.9
364
2597
UKC02
NOMESCO Finland
Cystoscopy
1.4
8.9
392
2838
R12
ICD-10 Finland
Heartburn
1.7
8.9
176
1052
F10.20
ICD-10 Finland
Alcohol dependence currently independent
2.6
8.8
62
243
R52.2
ICD-10 Finland
Other chronic pain
2.2
8.8
89
416
N05AX12
ATC
aripiprazole; systemic
2.3
8.8
79
351
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
3.2
8.8
43
134
WX892
NOMESCO Finland
Monitored bed care
1.7
8.7
197
1225
K13.00
ICD-10 Finland
Cheilitis NOS
5.9
8.7
23
39
SGC10
NOMESCO Finland
Covering pulpa of tooth
1.7
8.7
193
1190
-50
ICPC
Medication/prescr/renewal
2.0
8.7
110
567
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.8
8.7
141
792
EJA10
SPAT
NA
50.1
8.7
10
*
R01BA52
ATC
pseudoephedrine, combinations; oral
1.3
8.7
793
6472
F17.20
ICD-10 Finland
Addiction relationship caused by tobacco addiction relationship currently independent
4.2
8.7
31
74
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.6
8.7
207
1306
TJD20
NOMESCO Finland
Change of gastrostomy tube
7.6
8.6
19
25
D07CC01
ATC
betamethasone and antibiotics; topical
1.5
8.6
319
2230
ZZA00
NOMESCO Finland
Split skin graft
2.2
8.6
83
382
P29
ICPC
Psychological sympt/compl other
1.9
8.5
117
622
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.7
8.5
158
928
L04AD01
ATC
ciclosporin; systemic
2.8
8.5
52
188
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.0
8.5
110
571
R96
ICPC
Asthma
1.6
8.5
216
1387
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.6
8.4
211
1347
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
1.6
8.4
200
1260
J20
ICD-10 Finland
Acute bronchitis
1.6
8.4
234
1533
C06.21
ICD-10 Finland
Malignant tumor of the lower retromolar surface
90.3
8.4
9
*
A08
ICPC
Swelling
2.0
8.4
111
579
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
2.8
8.4
50
178
K11.2
ICD-10 Finland
Sialoadenitis
2.1
8.4
87
414
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
2.1
8.4
92
449
K05.12
ICD-10 Finland
Gingivitis (chronic) simple marginal
12.8
8.4
14
11
J45
ICD-10 Finland
Asthma
1.6
8.4
238
1570
RD210
NOMESCO Finland
NA
2.9
8.4
48
165
J01MA14
ATC
moxifloxacin; systemic
1.6
8.4
218
1406
N01
ICPC
Headache
1.6
8.3
199
1253
M01AE02
ATC
naproxen; oral, rectal
1.3
8.3
1464
12957
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.5
8.3
303
2113
K12.12
ICD-10 Finland
Stomatitis ulcerative
5.2
8.3
24
46
K14.6
ICD-10 Finland
Glossodynia
10.8
8.3
15
14
L04
ICPC
Chest symptom/complaint
1.8
8.3
141
807
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.0
8.2
95
472
K04.09
ICD-10 Finland
Pulpit UNS
2.1
8.2
93
459
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.5
8.2
260
1755
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.1
8.2
86
411
R06.0
ICD-10 Finland
Dyspnoea
1.3
8.2
616
4880
H53.1
ICD-10 Finland
Subjective visual disturbances
1.7
8.2
158
937
WX872
NOMESCO Finland
Intensive care
1.8
8.2
131
735
K08.80
ICD-10 Finland
Toothache NOS
1.7
8.2
178
1096
N06AB06
ATC
sertraline; oral
1.5
8.2
246
1644
ECA50
NOMESCO Finland
Parodontal operation
3.7
8.1
33
89
A29
ICPC
General symptom/complaint other
1.5
8.1
263
1787
SPD00
NOMESCO Finland
Fitting and preparation of total teeth prosthesis
3.2
8.1
40
126
ZZQ20
NOMESCO Finland
Free microvascular graft of skin, muscle and bone
33.4
8.1
10
*
N03AG01
ATC
valproic acid; systemic, rectal
1.8
8.1
143
830
K06.23
ICD-10 Finland
Irritative hyperplasia of edentulous ridge [denture hyperplasia]
6.8
8.1
19
28
ZX090
NOMESCO Finland
Other technic of radiotherapy
2.2
8.0
79
365
L57.0
ICD-10 Finland
Actinic keratosis
1.5
8.0
239
1594
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
2.4
8.0
65
273
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
1.6
8.0
196
1246
B35.3
ICD-10 Finland
Tinea pedis
2.0
8.0
94
472
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.7
8.0
165
1001
ZXD35
NOMESCO Finland
Usual procedure
2.0
8.0
93
463
SPC10
NOMESCO Finland
Attachment of standard crone of tooth
2.6
8.0
56
220
F10.09
ICD-10 Finland
Alcohol intoxication UNS
2.6
8.0
55
213
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.4
8.0
326
2329
L14
ICPC
Leg/thigh symptom/complaint
1.6
7.9
179
1112
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.3
7.9
68
296
A13
ICPC
Concern/fear medical treatment
2.7
7.9
51
190
127
Kela drug reimbursment
Transplant complication
3.0
7.9
43
145
D07XC01
ATC
betamethasone, combinations; topical
1.5
7.9
295
2068
M01AB05
ATC
diclofenac; systemic, rectal
1.2
7.9
1806
16426
R03AK07
ATC
formoterol and budesonide; inhalant
1.4
7.9
456
3469
G44.2
ICD-10 Finland
Tension-type headache
1.5
7.9
307
2169
K14.68
ICD-10 Finland
Other tongue pain
13.0
7.9
13
10
SPE00
NOMESCO Finland
Fitting and preparation of metal structure partial teeth prosthesis
2.5
7.9
59
241
SCC01
NOMESCO Finland
Simple fluorination of mouth or other corresponding procedure
2.2
7.8
73
331
P99
ICPC
Psychological disorders other
2.4
7.8
61
252
SPA47
NOMESCO Finland
Precision impression for denture
2.7
7.8
51
192
K60.2
ICD-10 Finland
Anal fissure, unspecified
2.8
7.8
47
169
UJF30
NOMESCO Finland
Ileoscopy through colon
1.5
7.8
235
1571
N05AX08
ATC
risperidone; systemic
1.7
7.8
173
1072
EDC38
NOMESCO Finland
Open reduction and fixation of fracture of body of mandible
10.8
7.8
14
13
EAB00
NOMESCO Finland
Suture of lip
10.8
7.8
14
13
N30.0
ICD-10 Finland
Acute cystitis
1.4
7.8
325
2332
C02.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of tongue
45.1
7.7
9
*
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
2.3
7.7
67
296
H92.0
ICD-10 Finland
Otalgia
1.9
7.7
115
630
J31.0
ICD-10 Finland
Chronic rhinitis
1.6
7.7
176
1099
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.7
7.6
168
1039
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
2.6
7.6
53
207
SPE90
NOMESCO Finland
Other fitting and preparation of partial tooth prosthesis
2.3
7.6
69
310
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.3
7.6
594
4729
F10.24
ICD-10 Finland
Alcohol depence active use
3.0
7.6
41
138
EDA10
NOMESCO Finland
Biopsy of mandible
6.7
7.6
18
27
C05.0
ICD-10 Finland
Malignant neoplasm: Hard palate
25.1
7.6
10
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.7
7.6
167
1032
K30
ICD-10 Finland
Functional dyspepsia
1.5
7.5
251
1718
K05.19
ICD-10 Finland
Gingivitis (chronic) ulcerative
2.4
7.5
59
245
R4120
NOMESCO Finland
Occupational therapy
1.7
7.5
157
956
Z01.7
ICD-10 Finland
Laboratory examination
1.5
7.5
265
1836
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
3.0
7.5
41
139
EAA30
NOMESCO Finland
Partial excision of lower lip
10.0
7.5
14
14
K60.1
ICD-10 Finland
Chronic anal fissure
2.4
7.5
60
254
T84.62
ICD-10 Finland
Osteitis associated with dental implants
4.6
7.5
24
52
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.7
7.5
148
887
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.6
7.5
168
1044
A99
ICPC
Disease/condition unspecnature/site
1.6
7.5
195
1261
P76
ICPC
Depressive disorder
1.8
7.5
132
763
K04.62
ICD-10 Finland
Periradicular abscess with fistula to mouth
2.2
7.5
75
351
R39.1
ICD-10 Finland
Other difficulties with micturition
2.1
7.5
76
361
EJC30
NOMESCO Finland
Reconstruction of tongue
80.3
7.4
8
*
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
3.0
7.4
40
135
P80
ICPC
Personality disorder
6.5
7.4
18
28
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
2.4
7.4
59
250
L04AX01
ATC
azathioprine; systemic
1.9
7.4
105
567
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.6
7.3
207
1362
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
3.8
7.3
29
77
L16
ICPC
Ankle symptom/complaint
1.5
7.3
231
1562
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.8
7.3
122
695
M54.1
ICD-10 Finland
Radiculopathy
1.9
7.3
99
526
N05BA12
ATC
alprazolam; oral
1.5
7.3
255
1760
H81
ICPC
Excessive ear wax
1.4
7.3
400
3011
H13
ICPC
Plugged feeling ear
1.4
7.3
428
3258
EJB50
NOMESCO Finland
Total glossectomy
+∞
7.3
7
*
Z43.1
ICD-10 Finland
Attention to gastrostomy
10.9
7.3
13
12
S04
ICPC
Lump/swelling localized
1.5
7.3
211
1400
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
1.5
7.3
281
1983
K10.3
ICD-10 Finland
Alveolitis of jaws
1.9
7.2
102
549
K03.1
ICD-10 Finland
Abrasion of teeth
2.2
7.2
71
330
K06.19
ICD-10 Finland
Gingival hyperplasia UNS
6.2
7.2
18
29
R07.3
ICD-10 Finland
Other chest pain
1.5
7.2
228
1540
R60.0
ICD-10 Finland
Localized oedema
1.5
7.2
268
1875
XF402
NOMESCO Finland
ECG with work load test
1.5
7.2
282
1995
N05BA06
ATC
lorazepam; systemic, sublingual
1.8
7.2
123
707
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.6
7.2
175
1113
N17
ICPC
Vertigo/dizziness
1.5
7.2
258
1795
C07AB07
ATC
bisoprolol; oral
1.2
7.2
1243
10917
L84
ICD-10 Finland
Corns and callosities
2.0
7.1
87
444
EJ1S1
NOMESCO Finland
Photography of tongue
20.1
7.1
10
5
A03
ICPC
Fever
1.4
7.1
323
2352
ZXD20
NOMESCO Finland
Day surgery
1.4
7.1
312
2258
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.7
7.1
146
887
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
7.1
715
5890
N03AE01
ATC
clonazepam; systemic
1.7
7.1
149
912
H29
ICPC
Ear symptom/complaint other
1.5
7.0
240
1654
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.6
7.0
155
962
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.5
7.0
275
1951
M54
ICD-10 Finland
Dorsalgia
1.5
7.0
261
1833
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
2.3
6.9
59
258
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
2.6
6.9
47
183
D02AE01
ATC
carbamide; topical
1.6
6.9
156
970
TKC20
NOMESCO Finland
Catheterisation of bladder
1.6
6.9
166
1052
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.4
6.9
292
2099
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.0
6.9
85
435
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
5.8
6.9
18
31
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.5
6.9
233
1600
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
1.7
6.9
139
842
K29.7
ICD-10 Finland
Gastritis, unspecified
1.9
6.9
91
480
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.5
6.8
206
1377
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.6
6.8
174
1119
SCF01
NOMESCO Finland
Preventive oral care by dental hygienist or dental assistant, restricted
2.0
6.8
78
389
M01AX17
ATC
nimesulide; oral
1.3
6.8
637
5190
JN4BD
NOMESCO Finland
Extensive body CT
1.4
6.8
270
1915
M70.6
ICD-10 Finland
Trochanteric bursitis
1.4
6.8
304
2205
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.8
6.8
110
621
R29
ICPC
Respiratory symptom/complaint other
1.7
6.8
135
813
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.7
6.8
121
705
E000006
ATC
NA
1.6
6.8
172
1102
K12.2
ICD-10 Finland
Cellulitis and abscess of mouth
3.2
6.8
33
104
K14.88
ICD-10 Finland
Other diseases of tongue
10.9
6.8
12
11
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
2.0
6.8
80
404
SPAT1301
SPAT
No procedures
1.3
6.8
790
6620
R35
ICD-10 Finland
Polyuria
1.6
6.8
148
915
T84.60
ICD-10 Finland
Gingivitis associated with dental implants
4.0
6.8
25
63
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
2.3
6.8
60
267
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
3.1
6.8
34
110
ZYC01
NOMESCO Finland
Remote contact by phone
1.8
6.8
108
609
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.7
6.8
146
899
C06.9
ICD-10 Finland
Malignant neoplasm: Mouth, unspecified
40.1
6.8
8
*
K13.02
ICD-10 Finland
Cheilitis angular
40.1
6.8
8
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.5
6.7
190
1254
SPA30
NOMESCO Finland
Grinding of a single crown and bridge pillar or a single post and crown
3.3
6.7
31
94
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.4
6.7
292
2107
L04AA06
ATC
mycophenolic acid; systemic
2.5
6.7
49
199
S10
ICPC
Boil/carbuncle
1.7
6.7
129
769
R50.9
ICD-10 Finland
Fever, unspecified
1.4
6.7
316
2317
A03FA01
ATC
metoclopramide; systemic, rectal
1.3
6.7
510
4041
UJC01
NOMESCO Finland
Scopy of lower throat
3.1
6.7
34
111
RK320
NOMESCO Finland
NA
3.6
6.7
28
79
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.6
6.7
163
1039
R83
ICPC
Respiratory infection other
1.3
6.7
468
3666
Z96.5
ICD-10 Finland
Presence of tooth-root and mandibular implants
4.9
6.7
20
41
S08
ICPC
Skin colour change
1.7
6.6
123
726
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
6.6
1030
8918
SDA10
NOMESCO Finland
Parodonthologic therapy of advnaced and complicated changes of alveolar bone
3.4
6.6
30
90
R05
ICD-10 Finland
Cough
1.3
6.6
472
3703
S01GX01
ATC
cromoglicic acid; ophthalmic
1.3
6.6
435
3373
SGB20
NOMESCO Finland
Filling of root of tooth with 2 root channels
1.7
6.6
133
804
K05.39
ICD-10 Finland
Periodontitis UNS
2.4
6.6
53
224
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
1.7
6.6
124
734
K04
ICPC
Palpitations/awareness of heart
1.7
6.6
119
698
R42
ICD-10 Finland
Dizziness and giddiness
1.3
6.6
527
4204
G47.3
ICD-10 Finland
Sleep apnoea
1.3
6.6
515
4097
SPD01
NOMESCO Finland
Mucosa-supported complete denture
3.9
6.6
25
65
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.4
6.5
327
2424
EBA00
SPAT
NA
2.3
6.5
54
234
K10.20
ICD-10 Finland
Osteomyelitis (neonatal) of jaw (acute)(chronic)(suppurative)
8.7
6.5
13
15
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.1
6.5
71
347
SPAT1310
SPAT
Counselling related to known health issue
1.3
6.5
786
6611
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.4
6.5
309
2271
K29.3
ICD-10 Finland
Chronic superficial gastritis
1.9
6.5
84
440
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
3.1
6.5
33
108
TQW99
NOMESCO Finland
Other minor procedure on skin
1.8
6.5
113
656
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.8
6.5
109
625
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.5
6.5
222
1532
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.5
6.4
243
1706
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
2.6
6.4
44
173
K13.3
ICD-10 Finland
Hairy leukoplakia
70.0
6.4
7
*
D00.06
ICD-10 Finland
Cancer in situ in another part of the tongue
70.0
6.4
7
*
C06.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of other and unspecified parts of mouth
70.0
6.4
7
*
GD1AD
NOMESCO Finland
Thorax CT examination
1.8
6.4
105
597
RS240
NOMESCO Finland
NA
14.3
6.4
10
7
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
1.7
6.4
115
672
K03.09
ICD-10 Finland
Abrasion of the teeth UNS
3.2
6.4
30
93
ZXA10
NOMESCO Finland
Bilateral
1.3
6.4
457
3589
SPC01
NOMESCO Finland
Fixed dental crown
2.8
6.4
37
131
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.6
6.3
150
946
DFF00
NOMESCO Finland
Pure tone audiometry
1.5
6.3
212
1452
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.6
6.3
161
1034
F31.31
ICD-10 Finland
Bipolar disorder depressive episode with somatic syndrome
4.4
6.3
21
48
L02
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle
1.9
6.3
91
496
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
3.4
6.3
28
83
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.4
6.3
327
2440
EB1MA
NOMESCO Finland
Cephalometry with X-ray
2.6
6.3
42
163
F34.1
ICD-10 Finland
Dysthymia
1.9
6.3
80
416
P16
ICPC
Acute alcohol abuse
2.6
6.3
41
156
4707
FHL
Dissection Colli radicalis
+∞
6.2
6
*
K14.39
ICD-10 Finland
Papillary hypertrophy of the tongue UNS
+∞
6.2
6
*
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
2.2
6.2
60
280
C00.1
ICD-10 Finland
Malignant neoplasm: External lower lip
26.7
6.2
8
*
C00.4
ICD-10 Finland
Malignant neoplasm: Lower lip, inner aspect
26.7
6.2
8
*
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
2.0
6.2
69
341
R03BA05
ATC
fluticasone; inhalant
1.3
6.2
426
3321
SPA60
NOMESCO Finland
Fitting of intermediary dental prosthesis structures, 1 to 3 units
2.9
6.2
36
127
L29
ICPC
Musculoskeletal sympt/complt other
1.5
6.2
175
1155
N03AF01
ATC
carbamazepine; oral, rectal
1.6
6.2
134
827
A03FA02
ATC
cisapride; oral, rectal
1.5
6.2
187
1255
U02
ICPC
Urinary frequency/urgency
1.4
6.2
302
2231
ZXE30
NOMESCO Finland
More than five and less than seven hours
1.7
6.2
122
735
ENA10
NOMESCO Finland
Biopsy of pharynx
6.3
6.2
15
24
K02
ICD-10 Finland
Dental caries
1.6
6.1
162
1056
M01AE03
ATC
ketoprofen; systemic, rectal
1.2
6.1
974
8437
IGY02
NOMESCO Finland
Psychiatric monitoring contact
2.6
6.1
41
160
S02.53
ICD-10 Finland
Fracture of tooth root
2.0
6.1
68
337
K02.8
ICD-10 Finland
Other dental caries
2.1
6.1
66
324
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
2.7
6.1
38
143
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
2.6
6.0
40
154
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
2.7
6.0
37
137
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
2.2
6.0
55
248
D05BB02
ATC
acitretin; oral
2.2
6.0
60
281
L05
ICPC
Flank/axilla symptom/complaint
1.7
6.0
129
793
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.4
6.0
309
2299
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
1.9
6.0
86
465
F41.1
ICD-10 Finland
Generalized anxiety disorder
1.9
6.0
84
451
C10AA01
ATC
simvastatin; oral
1.2
6.0
1149
10137
G04BD08
ATC
solifenacin; oral
1.6
6.0
164
1076
R52.0
ICD-10 Finland
Acute pain
2.0
6.0
70
354
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.5
6.0
170
1125
K80
ICPC
Cardiac arrhythmia NOS
1.5
6.0
176
1174
P15
ICPC
Chronic alcohol abuse
2.1
6.0
65
318
L13
ICPC
Hip symptom/complaint
1.3
6.0
393
3044
R95
ICPC
Chron obstructive pulmonary disease
2.0
6.0
67
331

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026389) Candida sp identified in Specimen by Organism specific culture
262
366
7.68
179.39
2.0
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1790
11599
2.16
102.15
2.6
2.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
729
3410
2.45
90.08
1.8
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1671
11905
1.80
59.51
2.2
2.0
pmol/l
97.6
95.2
1.08
864
6021
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2680
22308
1.99
55.16
9.0
7.7
u/l
80.1
78.7
0.80
2531
21006
(42870588) Differential panel, method unspecified - Blood
1395
9730
1.74
50.85
7.1
5.9
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1785
13347
1.72
50.39
6.6
6.1
mmol/l
1.2
1.2
0.02
1614
12074
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1961
15157
1.70
47.96
6.7
6.4
umol/l
11.4
11.4
0.03
1859
14390
(3013707) Erythrocyte sedimentation rate by Westergren method
2539
21143
1.82
47.08
5.2
4.2
mm/h
13.1
12.5
1.09
2337
19565
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
76
121
6.40
45.73
4.3
2.7
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
1753
13380
1.65
42.94
7.4
6.0
%
57.7
57.2
0.82
1624
12496
(3002030) Lymphocytes/100 leukocytes in Blood
1770
13571
1.64
42.35
7.7
6.2
%
27.1
27.8
1.91
1629
12621
(3019069) Monocytes/100 leukocytes in Blood
1737
13259
1.64
42.28
7.9
6.4
%
8.8
8.7
0.41
1612
12390
(3006315) Basophils [#/volume] in Blood
1828
14153
1.64
41.86
7.3
5.9
e9/l
0.0
0.0
0.68
1584
12192
(3013115) Eosinophils [#/volume] in Blood
1874
14626
1.64
41.32
7.6
6.1
e9/l
0.2
0.2
1.01
1641
12787
(3006504) Eosinophils/100 leukocytes in Blood
1725
13196
1.63
41.20
7.6
6.1
%
2.9
2.9
0.54
1598
12292
(3001604) Monocytes [#/volume] in Blood
1816
14088
1.63
40.83
7.3
5.9
e9/l
0.6
0.6
0.52
1573
12136
(3022096) Basophils/100 leukocytes in Blood
1685
12843
1.63
40.63
7.6
6.1
%
0.7
0.7
1.51
1556
11972
(3013650) Neutrophils [#/volume] in Blood by Automated count
2056
16465
1.64
40.49
10.4
9.2
e9/l
4.2
4.1
0.89
1792
14359
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1868
14641
1.62
39.86
7.4
6.9
mmol/l
1.2
1.2
1.55
1617
12372
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
513
2806
1.98
39.86
2.3
2.2
g/l
0.2
0.2
0.29
485
2636
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1033
6986
1.69
39.76
2.5
2.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1653
12596
1.61
39.47
5.1
4.9
g/l
35.4
35.4
0.15
1540
11723
(3019198) Lymphocytes [#/volume] in Blood
1839
14470
1.60
37.69
7.3
5.9
e9/l
1.8
1.9
1.64
1620
12693
(3044640) Blood type and Crossmatch panel - Blood
1249
9102
1.59
34.52
2.7
2.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2897
25838
1.87
34.25
5.8
4.8
mu/l
1.9
2.1
1.74
2631
23539
(3037467) Urinalysis macro (dipstick) panel - Urine
2303
19352
1.60
33.79
5.2
4.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
551
3256
1.83
33.33
2.0
1.8
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
971
6737
1.62
32.52
1.6
1.5
nmol/l
19.4
20.9
2.58
842
5723
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2208
18454
1.57
32.37
3.8
3.2
u/l
55.2
50.9
1.19
2033
17082
(3015377) Calcium [Moles/volume] in Serum or Plasma
1326
9934
1.55
31.74
3.6
3.4
mmol/l
2.4
2.4
0.05
1119
8641
(3013826) Glucose [Moles/volume] in Serum or Plasma
2054
16962
1.54
31.15
5.6
4.8
mmol/l
6.8
6.8
0.19
1951
15939
(3031040) Bacteria [#/volume] in Urine by Automated count
2203
18481
1.56
31.06
5.4
4.6
e6/l
468.8
1856.2
1.49
20
263
(4010399)
381
2050
1.97
30.60
1.5
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3070
28119
2.05
30.56
19.6
14.8
mg/l
23.9
23.9
0.04
2581
22353
(3032080) INR in Blood by Coagulation assay
1523
11835
1.52
30.39
7.3
9.3
inr
1.2
1.3
1.60
297
3362
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
597
3706
1.74
30.29
4.8
4.6
%
32.6
32.4
0.17
413
2449
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1203
8929
1.54
29.44
2.3
2.2
u/l
223.0
219.7
0.04
1126
8364
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2488
21577
1.59
29.22
4.7
4.0
pmol/l
14.9
14.9
0.25
2235
19548
(3019309) Folate [Moles/volume] in Red Blood Cells
795
5372
1.63
29.12
1.7
1.8
nmol/l
1099.7
1167.7
1.12
587
4062
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
851
5850
1.61
29.04
1.3
1.2
u/ml
1.1
1.7
1.40
192
1555
(40758558) Short blood count panel - Blood
1013
7285
1.56
28.35
8.2
6.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
523
3187
1.76
28.15
2.2
1.8
%
1.7
1.5
4.82
445
2788
(3019225) pH of Specimen
500
3015
1.77
27.89
4.1
4.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
3152
29345
2.18
26.96
21.8
17.0
mmol/l
139.4
139.7
10.03
3091
28621
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1503
11841
1.49
26.93
2.5
2.3
nmol/l
76.6
78.5
1.81
1332
10574
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1219
9207
1.51
26.85
3.5
3.3
u/l
39.6
37.3
0.18
1150
8727
(3007164) IgA [Mass/volume] in Serum or Plasma
761
5178
1.61
26.78
1.5
1.5
g/l
2.5
2.5
0.04
430
3113
(3033658) Prothrombin time (PT) actual/Normal
1016
7387
1.54
26.74
5.0
3.9
%
90.6
90.0
0.28
1000
7201
(3023103) Potassium [Moles/volume] in Serum or Plasma
3155
29434
2.16
26.01
21.9
17.2
mmol/l
4.0
4.0
0.59
3089
28673
(3003458) Phosphate [Moles/volume] in Serum or Plasma
589
3843
1.65
24.31
5.8
6.0
mmol/l
1.0
1.0
0.87
554
3560
(3042936) Bacteria identified in Isolate by Culture
619
4098
1.63
24.08
2.1
2.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
1057
7908
1.49
23.67
4.7
4.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1185
9104
1.47
23.06
2.7
2.6
u/l
58.2
58.6
0.11
1087
8409
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2893
26471
1.66
22.66
6.6
5.9
mmol/mol
40.5
40.1
1.04
2669
24429
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1630
13339
1.43
22.38
4.1
4.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
246
1268
2.01
22.15
1.2
1.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
694
4812
1.56
21.97
4.1
3.4
mmol/l
0.8
0.8
1.88
643
4498
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3189
30110
2.14
21.60
13.8
10.8
u/l
26.4
26.6
0.20
3093
29048
(3020779) Urea [Moles/volume] in Serum or Plasma
419
2586
1.71
21.18
6.4
7.7
mmol/l
8.2
9.9
6.73
396
2478
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
500
3266
1.62
20.25
3.1
2.8
umol/l
8.5
8.2
0.09
416
2844
(3052851) Hemolysis interference index of Serum or Plasma
180
860
2.15
19.83
3.6
3.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
779
5663
1.49
19.44
4.4
3.8
ng/l
635.0
444.8
0.30
636
4513
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
427
2707
1.66
19.43
2.8
2.4
u/l
39.1
57.3
0.48
351
2335
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
940
7102
1.45
19.20
2.4
2.2
mg/l
3.0
3.0
0.17
805
6054
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1405
11409
1.40
19.07
3.0
2.8
ug/l
123.7
139.2
1.92
1285
10507
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
665
4708
1.51
18.79
2.0
1.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2903
26843
1.59
18.77
17.2
13.8
ml/min/173m2
80.3
79.1
2.22
2477
22224
(3048689) Calprotectin [Mass/mass] in Stool
488
3229
1.60
18.64
2.1
2.2
ug/g
127.2
151.1
0.68
390
2553
(3037522) Nuclear Ab [Titer] in Serum
547
3720
1.56
18.56
1.5
1.3
titre
737.5
528.1
1.14
121
785
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
348
2118
1.72
18.41
1.8
1.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
1116
8756
1.41
18.31
4.7
4.2
ph
7.4
7.4
1.72
148
1673
(3017143) Hepatitis C virus Ab [Presence] in Serum
434
2803
1.63
18.30
1.6
1.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
3100
29189
1.79
18.26
17.5
13.9
—
—
—
0
0
(3000492) Spirometry study
417
2684
1.63
17.80
1.7
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
581
4083
1.51
16.82
1.3
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2967
27715
1.60
16.78
5.3
4.7
mmol/l
6.0
6.0
0.47
2688
25200
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
466
3153
1.55
16.02
1.6
1.6
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
59
180
3.32
15.99
1.3
1.4
titre
24.0
66.3
—
5
19
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
294
1776
1.72
15.94
2.0
1.9
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
3243
31129
2.16
15.93
28.8
21.7
e9/l
250.8
250.0
0.27
3181
30327
(3024731) MCV [Entitic volume]
3242
31137
2.14
15.55
28.7
21.7
fl
91.8
91.2
11.12
3207
30678
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
669
4905
1.45
15.54
3.0
2.7
e6/l
0.9
1.1
1.61
385
2806
(3035941) MCH [Entitic mass]
3242
31138
2.14
15.53
28.6
21.6
pg
30.5
30.4
5.34
3207
30677
(3026361) Erythrocytes [#/volume] in Blood
3242
31140
2.13
15.49
28.8
21.7
e12/l
4.4
4.5
9.02
3169
30241
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
626
4538
1.47
15.41
3.1
2.9
e6/l
2.4
2.5
0.11
338
2454
(3010813) Leukocytes [#/volume] in Blood
3242
31145
2.13
15.41
28.8
21.8
e9/l
6.8
6.7
2.11
3169
30244
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
730
5449
1.43
15.38
3.3
3.0
mmol/l
2.5
2.5
0.24
620
4786
(3000963) Hemoglobin [Mass/volume] in Blood
3242
31147
2.13
15.37
28.9
21.8
g/l
134.2
135.4
4.72
3209
30691
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
286
1739
1.70
15.13
1.8
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
754
9747
0.71
15.00
2.9
2.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
293
1807
1.68
14.69
1.4
1.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
571
4110
1.47
14.50
2.4
2.6
g/l
2.3
2.3
0.34
523
3809
(3013512) EKG study
1070
8627
1.35
13.96
4.4
3.9
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1059
8551
1.35
13.61
2.8
3.0
ng/l
1317.5
1340.8
0.04
896
7321
(36660697) Celiac disease serology panel - Serum
323
2088
1.61
13.43
1.2
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
261
1599
1.69
13.41
1.9
1.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1331
11137
1.32
13.32
3.9
3.7
ng/l
29.6
92.9
0.92
936
7853
(46235355) HIV 1 and 2 tests - Meaningful Use set
513
3681
1.46
13.15
1.8
1.7
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
456
3209
1.49
12.88
2.6
2.6
%
1.9
1.8
0.57
385
2855
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
60
211
2.88
12.85
1.5
1.5
u/ml
14.8
22.0
0.93
12
42
(3022948) Iron [Moles/volume] in Serum or Plasma
599
4448
1.42
12.73
2.4
2.6
umol/l
12.3
13.0
1.75
559
4130
(3009508) Creatinine [Moles/volume] in Urine
1122
9214
1.33
12.64
3.5
3.2
mmol/l
6.9
7.4
3.15
917
7730
(3026493) Urate [Moles/volume] in Serum or Plasma
950
7632
1.34
12.39
2.9
2.7
umol/l
2879.5
5285.6
1.38
808
6630
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1850
16293
1.30
12.35
3.0
2.7
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
125
626
2.04
12.25
3.0
3.0
umol/l
35.7
37.2
0.23
111
533
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3023
28690
1.53
12.24
5.7
5.1
mmol/l
2.7
2.8
6.51
2781
26345
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
249
1544
1.66
12.22
2.6
2.4
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
193
1117
1.77
12.17
3.2
4.0
mmol/l
24.9
25.0
0.17
181
1035
(3022217) INR in Platelet poor plasma by Coagulation assay
524
3828
1.44
12.15
28.5
25.0
inr
1.4
1.4
0.00
59
529
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
183
1044
1.80
12.11
2.3
2.3
ug/l
640.7
696.0
0.06
176
984
(3022145) Colonoscopy Study observation
457
3260
1.47
12.01
1.3
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
298
1941
1.59
11.99
2.7
3.1
e9/l
4.1
4.1
0.01
202
1501
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
121
604
2.04
11.98
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
121
604
2.04
11.98
1.3
1.3
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
246
1533
1.65
11.84
9.0
9.6
mmol/l
24.5
24.4
0.28
233
1432
(36304419) Bacteria [Presence] in Urine
952
7695
1.33
11.80
3.7
3.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
524
3847
1.43
11.80
2.5
2.6
%
20.7
22.8
3.23
447
3281
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
633
4811
1.39
11.67
1.4
1.3
iu/ml
41.8
34.8
0.54
186
1523
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
205
1224
1.72
11.59
1.9
1.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
546
4055
1.41
11.51
1.5
1.4
—
—
—
0
0
(4035726)
378
2631
1.49
11.22
1.4
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
826
6609
1.33
10.83
3.8
3.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
261
1688
1.59
10.81
1.4
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2862
26996
1.40
10.80
4.5
4.1
mmol/l
1.4
1.3
1.38
2594
24590
(3009542) Hematocrit [Volume Fraction] of Blood
2705
25286
1.36
10.78
21.9
15.7
%
39.4
39.7
0.85
1880
17671
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
790
6285
1.34
10.77
1.8
1.8
mg/l
1.1
1.3
1.03
609
4820
(3005719) IgG [Mass/volume] in Serum or Plasma
316
2141
1.53
10.66
3.2
2.8
g/l
10.8
10.5
0.50
289
1948
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
218
1354
1.65
10.64
4.1
3.9
mmol/l
23.9
24.2
0.48
196
1217
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
188
1123
1.71
10.63
1.8
1.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
1064
8838
1.30
10.59
3.5
3.2
mg/l
421.7
320.8
0.27
665
5510
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2962
28146
1.44
10.37
5.1
4.6
mmol/l
4.6
4.7
5.00
2728
25984
(3030467) Casts [#/volume] in Urine by Automated count
963
7924
1.30
10.22
3.7
3.1
e6/l
0.4
0.4
0.67
731
5981
(3023520) Reticulocytes [#/volume] in Blood
346
2415
1.48
10.10
2.2
2.6
e9/l
73.7
70.4
0.82
259
1842
(3022313) Gas panel - Capillary blood
211
1319
1.64
10.05
3.1
3.7
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
71
308
2.33
10.02
3.4
3.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
146
828
1.80
9.90
1.5
1.7
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
153
880
1.77
9.90
1.4
1.4
ug/g
265.8
274.9
0.24
87
519
(3002256) Pathology report gross observation
502
3765
1.39
9.90
1.4
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
66
279
2.39
9.87
4.5
2.7
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
136
756
1.83
9.85
2.7
3.1
mg/l
1.4
1.6
2.11
126
698
(3003396) Base excess in Arterial blood by calculation
456
3377
1.41
9.67
7.7
7.4
mmol/l
1.2
1.1
0.11
366
2645
(3018095) Leukocytes [#/volume] in Urine
1179
10012
1.27
9.65
4.3
3.7
e6/l
59.8
108.0
2.31
830
7121
(3014765) Yersinia sp identified in Stool by Organism specific culture
145
831
1.78
9.51
1.2
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
1103
9304
1.28
9.50
4.0
4.0
mg/mmol
6.8
8.6
0.94
662
5798
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
178
1081
1.68
9.49
2.1
2.5
g/l
3.0
3.1
0.17
135
849
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
440
3251
1.41
9.45
2.0
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
210
1332
1.61
9.45
1.0
1.0
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
456
3391
1.40
9.43
7.7
7.4
kpa
12.1
12.3
0.36
441
3243
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
456
3391
1.40
9.43
7.7
7.4
kpa
5.2
5.1
0.78
439
3244
(3000991) Gas panel - Venous blood
340
2401
1.46
9.35
9.0
8.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
154
904
1.74
9.30
2.0
2.2
g/l
38.6
37.7
1.08
126
776
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
439
3256
1.40
9.21
2.0
1.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
145
839
1.76
9.21
1.2
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2934
27937
1.39
9.19
5.1
4.5
mmol/l
1.5
1.5
1.01
2686
25638
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
136
774
1.79
9.14
1.4
1.2
u/ml
15.7
36.1
—
7
41
(3018677) aPTT in Platelet poor plasma by Coagulation assay
571
4426
1.35
9.11
2.0
2.1
s
29.8
29.7
0.17
556
4293
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
131
740
1.80
9.03
1.6
1.3
iu/ml
26.6
13.3
—
7
16
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
164
988
1.69
9.03
2.0
2.5
g/l
0.5
1.0
1.51
131
857
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
589
4598
1.34
8.95
1.3
1.2
u/ml
11.5
12.5
0.12
176
1763
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
174
1076
1.65
8.68
2.1
2.4
g/l
10.3
10.1
0.22
134
917
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
141
825
1.74
8.64
1.2
1.1
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
172
1062
1.65
8.64
1.3
1.2
u/ml
2.1
1.1
0.34
18
93
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
49
193
2.56
8.56
2.1
2.2
e6/l
870.3
691.5
0.73
23
87
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
77
370
2.11
8.54
1.7
1.4
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
250
1690
1.52
8.53
1.8
1.8
g/l
1.3
1.4
0.22
230
1534
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
59
254
2.35
8.53
1.3
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
258
1756
1.51
8.52
1.3
1.3
au/ml
15.7
60.6
—
5
80
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
137
799
1.74
8.49
2.0
2.4
g/l
0.0
0.0
0.00
121
740
(3014111) Lactate [Moles/volume] in Serum or Plasma
351
2540
1.43
8.46
7.9
7.0
mmol/l
1.4
1.4
0.23
340
2454
(3007566) Smooth muscle Ab [Titer] in Serum
133
770
1.76
8.46
1.2
1.2
titre
88.3
91.0
—
6
58
(3005988) Vibrio sp identified in Specimen by Organism specific culture
77
372
2.09
8.42
1.7
1.4
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
438
3295
1.38
8.42
4.8
4.3
u/l
236.1
248.2
1.16
408
3120
(3036481) Cortisol [Moles/volume] in Serum or Plasma
356
2587
1.42
8.38
2.7
2.2
nmol/l
365.9
370.7
0.17
319
2370
(3009466) Valproate [Moles/volume] in Serum or Plasma
81
401
2.05
8.31
5.9
5.1
umol/l
358.5
361.1
0.06
69
349
(3014576) Chloride [Moles/volume] in Serum or Plasma
483
3702
1.36
8.25
8.2
6.8
mmol/l
103.7
104.3
1.75
473
3624
(3024980) IgG subclass 4 [Mass/volume] in Serum
84
423
2.01
8.23
1.4
1.6
g/l
0.6
0.8
1.39
57
321
(3026008) Bacteria identified in Urine by Culture
1022
8659
1.26
8.22
3.6
3.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
125
717
1.77
8.22
1.3
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
76
369
2.08
8.21
1.7
1.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
182
1155
1.61
8.20
2.1
2.4
g/l
3.9
3.8
0.34
134
827
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
182
1156
1.61
8.17
2.1
2.4
g/l
7.3
7.4
0.28
137
865
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
182
1156
1.61
8.17
2.1
2.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
316
2258
1.44
8.16
3.8
3.8
ng/l
86.4
91.3
0.46
266
1935
(3002582) Erythrocytes [#/volume] in Urine
1013
8596
1.26
8.00
3.7
3.3
e6/l
153.6
69.5
0.31
775
6605
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
143
860
1.69
7.96
2.0
2.3
g/l
0.1
0.0
0.69
126
796
(3016502) Oxygen saturation in Arterial blood
404
3034
1.38
7.83
8.2
7.7
%
95.8
95.6
0.26
394
2934
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
76
376
2.04
7.83
1.7
1.4
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
124
723
1.74
7.73
1.4
1.2
u/ml
4.8
7.1
0.48
31
124
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
133
791
1.71
7.72
2.0
2.4
g/l
0.0
0.0
0.00
118
739
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
76
380
2.02
7.62
1.7
1.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
274
1931
1.46
7.62
2.4
2.4
au/ml
18.2
23.5
0.38
12
82
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
122
711
1.74
7.62
1.5
1.2
u/ml
12.0
7.5
0.22
19
74
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
341
2501
1.40
7.61
2.5
2.9
ng/l
229.0
189.5
0.79
310
2275
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
127
750
1.72
7.57
1.2
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
286
2044
1.44
7.38
2.6
2.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
476
3705
1.33
7.30
7.9
7.0
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
128
769
1.69
7.18
1.2
1.2
titre
338.3
1251.0
—
6
21
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
139
854
1.65
7.17
1.9
1.8
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
330
2433
1.40
7.15
2.7
2.7
g/l
67.1
66.5
0.81
292
2216
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
132
801
1.67
7.14
2.1
1.9
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
46
193
2.40
7.10
1.2
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
46
193
2.40
7.10
1.2
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
191
1271
1.53
7.05
1.3
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
120
713
1.71
7.02
1.8
1.7
e6/l
17497.7
13527.7
0.34
81
513
(3024522) Salmonella sp identified in Specimen by Organism specific culture
74
378
1.98
7.02
1.7
1.4
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
46
194
2.39
7.02
1.2
1.2
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
65
317
2.07
7.00
1.4
1.3
mosm/kgh2o
282.5
277.5
0.84
56
244
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
157
1004
1.59
6.90
1.6
1.6
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
46
196
2.37
6.87
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
46
196
2.37
6.87
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
46
196
2.37
6.87
1.2
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
926
7889
1.24
6.86
1.7
1.7
mmol/l
1.4
1.4
0.96
811
6598
(3025130) Human papilloma virus identified in Specimen
58
273
2.14
6.85
1.7
1.8
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
371
2808
1.36
6.84
8.6
8.2
g/l
119.9
121.6
0.90
364
2709
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
49
216
2.29
6.78
1.3
1.1
u/ml
2.2
3.7
—
5
13
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
86
468
1.86
6.78
1.2
1.2
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
59
281
2.12
6.77
1.9
1.3
iu/ml
62.0
27.3
—
7
12
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
101
580
1.76
6.68
1.3
1.2
u/ml
18.8
4.0
—
10
43
(21494815) CD4 cells/100 lymphocytes in Specimen
50
225
2.24
6.60
1.9
2.1
%
48.6
43.8
—
10
28
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
50
226
2.23
6.54
1.3
1.1
u/ml
113.8
43.1
—
5
10
(3021788) Differential panel - Synovial fluid
93
527
1.79
6.45
1.6
1.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
234
1655
1.44
6.41
1.3
1.3
u/ml
261.3
194.8
0.61
215
1518
(3026782) Osmolality of Urine
675
5587
1.26
6.41
3.0
2.8
mosm/kgh2o
535.4
545.5
0.48
561
4764
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
50
229
2.20
6.34
1.3
1.1
u/ml
33.6
42.4
—
7
20
(3024891) Influenza virus A+B Ag [Presence] in Specimen
115
696
1.68
6.32
1.2
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
267
1940
1.41
6.31
1.2
1.3
—
—
—
0
0
(4198724)
25
81
3.10
6.31
2.2
1.7
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
253
1821
1.42
6.30
3.2
3.7
kpa
5.2
5.2
0.46
233
1688
(3009343) pH of Capillary blood
250
1798
1.42
6.26
3.2
3.7
ph
7.4
7.4
0.21
16
230
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
49
224
2.21
6.25
1.1
1.1
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
128
799
1.63
6.25
2.2
1.6
g/l
0.2
0.2
1.49
121
760
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
132
831
1.61
6.22
2.2
1.6
g/l
1.2
1.2
0.04
127
793
(3011288) Drugs identified in Urine by Screen method
75
403
1.88
6.18
6.4
2.9
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
16
39
4.12
6.08
1.0
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
15
35
4.30
6.02
1.0
1.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
240
1727
1.42
6.00
3.2
3.6
mmol/l
1.4
1.9
1.51
190
1299
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
223
1585
1.44
5.97
9.3
10.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
99
586
1.71
5.93
3.7
2.0
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
177
1206
1.49
5.89
1.7
1.5
u/ml
4.8
19.5
—
8
32
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
148
974
1.54
5.80
2.8
3.0
u/ml
0.3
0.4
0.85
84
564
(3009214) Lutropin [Units/volume] in Serum or Plasma
97
575
1.71
5.79
1.3
1.4
u/l
12.4
9.8
0.74
70
475
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
190
1320
1.47
5.74
1.6
1.8
g/l
1.5
1.6
0.34
166
1145
(3015736) pH of Urine
1199
10635
1.20
5.71
3.5
3.5
—
5.8
—
0
8
(3012544) pH of Venous blood
357
2764
1.33
5.66
4.2
3.6
—
7.4
—
0
12
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
46
214
2.17
5.66
1.2
1.1
titre
136.3
118.2
—
8
44
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
333
2554
1.34
5.63
2.1
2.4
ug/l
12.0
7.0
0.84
284
2259
(1001926) Buprenorphine [Presence] in Urine by Screen method
85
490
1.75
5.61
3.8
2.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
83
478
1.76
5.50
1.4
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
66
355
1.88
5.46
1.4
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
711
6016
1.23
5.46
2.8
2.6
e6/l
4.8
5.5
0.85
609
5280
(3051651) Icteric interference index of Serum or Plasma
40
179
2.25
5.41
3.0
3.5
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
54
272
2.00
5.41
1.9
2.2
e9/l
1.1
1.1
0.05
30
163
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
77
438
1.78
5.34
1.1
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
103
635
1.64
5.33
3.7
2.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
160
1092
1.49
5.31
2.5
2.5
—
—
—
0
0
(3044889) 12 lead EKG panel
2178
20420
1.19
5.30
4.2
3.9
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
103
638
1.63
5.24
3.7
2.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
102
631
1.64
5.22
3.7
2.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
30
120
2.51
5.20
1.2
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
130
855
1.54
5.14
1.6
1.6
iu/ml
1.2
7.2
0.40
27
170
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
232
1707
1.39
5.13
1.2
1.2
iu/ml
167.5
150.4
0.23
77
625
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
94
573
1.66
5.10
7.3
5.5
iu/ml
383.2
598.8
0.31
14
87
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
144
974
1.50
5.01
3.4
2.8
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
24
88
2.74
4.93
1.5
2.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
211
1541
1.39
4.89
1.3
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
185
1321
1.42
4.88
2.2
2.0
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
29
118
2.47
4.87
3.0
2.4
umol/l
116.2
157.5
0.40
15
69
(3027944) Amphetamines [Presence] in Urine
99
620
1.61
4.85
2.9
1.9
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1028
9107
1.19
4.77
5.0
4.8
ug/l
3.0
2.7
0.12
916
8197
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
100
633
1.60
4.70
2.0
1.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
102
650
1.59
4.66
1.6
1.4
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
22
80
2.76
4.61
1.5
1.7
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
23
86
2.69
4.58
1.7
1.3
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
337
2669
1.29
4.54
4.2
3.6
kpa
5.9
5.8
0.22
332
2589
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
94
593
1.60
4.50
1.6
1.7
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
50
265
1.90
4.40
1.3
1.4
g/l
2.5
2.9
1.42
36
182
(3024139) IgG subclass 3 [Mass/volume] in Serum
50
265
1.90
4.40
1.3
1.4
g/l
0.5
0.4
0.77
35
183
(3027135) IgG subclass 1 [Mass/volume] in Serum
50
265
1.90
4.40
1.3
1.4
g/l
8.0
6.8
0.69
35
182
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
50
266
1.89
4.35
1.3
1.4
u/l
30.6
33.1
0.17
41
214
(3021589) Normoblasts [#/volume] in Blood
1373
12526
1.16
4.32
10.6
9.7
e9/l
0.0
0.0
0.17
1103
10239
(4062490)
50
267
1.89
4.31
1.3
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
257
1979
1.32
4.27
5.1
4.9
—
—
—
0
0
(4015189)
21
78
2.70
4.25
3.0
2.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
263
2035
1.32
4.23
2.6
2.3
nmol/l
12.0
13.1
1.24
218
1802
(3020191) Ethanol [Moles/volume] in Serum or Plasma
44
227
1.95
4.20
1.7
1.4
promille
1.5
1.2
0.52
34
174
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
137
954
1.45
4.18
3.4
3.6
mg/l
35.7
65.1
1.12
113
774
(3034860) Kappa light chains.free [Mass/volume] in Serum
137
954
1.45
4.18
3.4
3.5
mg/l
44.5
59.9
1.01
115
775
(3037121) Protein [Mass/volume] in Urine
141
988
1.45
4.16
2.7
3.1
g/l
0.2
0.3
1.22
61
391
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
136
951
1.45
4.07
1.6
1.6
titre
608.3
421.3
—
6
45
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
117
797
1.48
4.00
1.5
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
33
157
2.11
3.93
1.2
1.2
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
115
784
1.48
3.93
2.9
2.3
%
210.8
192.5
1.23
110
749
(3002032) Base excess in Venous blood by calculation
330
2659
1.27
3.90
4.2
3.6
mmol/l
1.5
2.0
1.37
282
2149
(3024928) Oxygen saturation in Venous blood
94
615
1.54
3.89
3.3
2.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
94
616
1.54
3.87
1.8
1.7
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
87
561
1.57
3.85
1.3
1.2
u/ml
58.7
38.6
0.64
17
64
(3023419) Bacteria identified in Sputum by Culture
65
390
1.68
3.83
2.4
2.6
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
28
126
2.23
3.83
1.3
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
93
611
1.54
3.79
1.4
1.3
miu/ml
303.6
203.9
1.14
31
259
(3008757) Leukocyte morphology finding [Identifier] in Blood
56
324
1.74
3.77
4.1
4.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1504
13910
1.15
3.75
3.9
3.8
estimate
0.0
0.0
1.08
197
2489
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
19
72
2.65
3.72
2.1
1.9
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
40
210
1.92
3.67
1.6
1.5
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
30
142
2.12
3.64
5.9
6.0
u/ml
35.2
61.5
—
9
35
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
45
248
1.83
3.57
1.0
1.0
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
100
677
1.49
3.56
1.7
1.8
iu/l
3.7
4.6
0.55
26
229
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
63
384
1.65
3.53
1.2
1.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
52
303
1.73
3.44
3.5
3.4
%
57.8
56.8
0.13
38
198
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
26
120
2.18
3.38
1.3
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
68
428
1.60
3.37
1.1
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
703
6195
1.17
3.33
1.6
1.7
pmol/l
458.0
29010738.5
4.57
570
5143
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
34
175
1.95
3.33
1.4
1.1
u/l
81.2
79.4
0.05
29
154
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
120
854
1.42
3.33
1.3
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
379
3161
1.22
3.31
3.7
4.1
ug/l
33.5
21.6
0.25
313
2571
(3021601) Nitrite [Presence] in Urine by Test strip
1479
13749
1.14
3.27
5.1
5.1
estimate
0.0
0.0
0.80
207
2572
(3016038) Potassium [Moles/volume] in Urine
34
177
1.93
3.23
1.1
1.1
mmol/l
28.0
35.3
1.66
29
154
(4024509)
50
294
1.71
3.23
1.6
1.6
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
18
72
2.51
3.20
1.1
1.0
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
32
593
0.54
3.19
4.4
3.1
mmol/l
7.0
7.5
0.64
32
577
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
11
33
3.34
3.19
2.0
1.9
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
114
811
1.42
3.18
2.6
2.4
g/l
3.7
3.6
0.49
106
771
(3003181) Sodium [Moles/volume] in Urine
79
524
1.52
3.14
1.4
1.3
mmol/l
59.2
61.0
0.17
68
422
(21494890) Protein electrophoresis panel - 24 hour Urine
52
312
1.68
3.13
2.5
2.1
—
—
—
0
0
(4211845)
28
139
2.02
3.05
5.2
3.4
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
62
393
1.59
3.02
2.3
2.5
u/ml
2800.8
1177.0
0.24
62
381
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
62
393
1.59
3.02
4.7
6.6
mg/l
11.3
12.0
0.60
54
364
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
37
204
1.82
2.98
1.9
2.1
%
15.8
13.5
0.40
17
77
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
59
371
1.60
2.98
1.9
2.3
mg/l
40.9
22.7
0.88
14
92
(3003888) Timothy IgE Ab [Units/volume] in Serum
56
348
1.62
2.96
1.1
1.1
u/ml
1.1
4.6
3.40
32
167
(3006462) Nitrate [Presence] in Urine
26
127
2.06
2.96
5.5
3.6
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
18
76
2.38
2.89
1.3
1.3
ug/l
7.9
8.9
0.70
18
76
(3044941) Cell count panel - Synovial fluid
72
478
1.52
2.88
1.7
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
234
1882
1.26
2.87
3.5
3.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
287
2365
1.23
2.84
2.6
2.7
ml/min/173m2
70.6
64.6
1.69
131
961
(3024354) Oxygen [Partial pressure] in Venous blood
269
2203
1.24
2.82
3.6
2.9
kpa
4.6
4.6
0.06
264
2129
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
28
144
1.95
2.79
1.6
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
187
2360
0.78
2.78
3.9
4.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
181
1416
1.29
2.78
1.8
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
45
728
0.61
2.76
4.4
4.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
172
2191
0.77
2.76
1.5
1.4
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
37
210
1.77
2.74
1.9
2.1
%
74.2
72.2
0.49
37
196
(3035637) Corticotropin [Mass/volume] in Plasma
54
340
1.60
2.74
1.3
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
650
7282
0.87
2.73
3.4
3.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
44
263
1.68
2.73
1.1
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1465
13717
1.12
2.71
3.8
3.8
estimate
0.0
0.0
0.00
201
2530
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
35
196
1.79
2.71
1.3
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
210
1680
1.27
2.71
3.4
3.3
pmol/l
4.4
4.4
0.37
185
1492
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
44
264
1.68
2.69
1.4
1.7
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
24
119
2.02
2.66
1.3
1.2
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
25
126
1.99
2.65
27.5
31.4
ug/l
7.3
7.6
0.24
19
112
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
12
43
2.80
2.64
2.4
2.0
umol/l
17.3
18.5
0.24
12
43
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
30
162
1.86
2.61
4.2
2.7
%
32.4
38.7
0.57
12
56
(40761535) Cells panel - Urine sediment
289
2406
1.22
2.61
3.5
3.5
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
101
733
1.39
2.58
1.8
2.0
mg/l
10.2
11.7
1.23
89
679
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
9
25
3.61
2.57
1.0
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
61
402
1.53
2.56
1.1
1.1
u/ml
1.3
1.8
0.28
28
164
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
6
11
5.46
2.54
1.2
1.6
nmol/l
13.8
14.1
—
6
11
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
594
5276
1.15
2.52
3.1
3.0
ug/l
0.6
0.8
3.28
396
3456
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
36
209
1.73
2.50
1.3
1.4
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
39
632
0.61
2.45
3.9
3.0
mmol/l
1.7
1.6
0.16
39
612
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
96
699
1.38
2.42
1.1
1.1
u/ml
1.6
5.5
—
10
77
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
31
174
1.79
2.41
1.2
1.6
u/l
5.5
7.1
0.64
25
148
(40763480) Human metapneumovirus Ag [Presence] in Specimen
6
12
5.01
2.40
1.3
2.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
87
625
1.40
2.38
1.6
1.5
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
15
65
2.31
2.31
1.4
1.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
31
177
1.76
2.30
1.0
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
34
200
1.71
2.28
2.2
2.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
28
156
1.80
2.25
2.0
1.8
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
31
179
1.74
2.22
1.6
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
110
832
1.33
2.21
1.4
1.7
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
19
93
2.05
2.21
1.1
1.2
g/l
38.8
38.2
0.08
12
48
(3027456) Digoxin [Moles/volume] in Serum or Plasma
82
592
1.39
2.21
2.7
3.2
nmol/l
0.8
0.8
0.60
54
455
(3037692) Legionella sp identified in Specimen by Organism specific culture
22
114
1.94
2.20
1.5
1.4
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
10
242
0.41
2.20
1.8
2.3
ml
589.4
630.6
—
5
161
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
44
280
1.58
2.19
1.3
1.3
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
29
165
1.76
2.19
3.1
2.1
umol/l
16.8
11.0
0.30
20
106
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
25
136
1.84
2.17
1.7
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
25
136
1.84
2.17
1.6
1.4
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
15
67
2.24
2.17
1.3
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
93
688
1.36
2.17
2.8
2.2
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
18
87
2.07
2.16
1.9
2.1
%
7.3
10.3
0.97
18
77
(3008401) Mugwort IgE Ab [Units/volume] in Serum
51
337
1.52
2.16
1.1
1.1
u/ml
0.8
1.5
0.53
29
140
(40760888) Immunoglobulin light chains.free panel - Serum
95
706
1.36
2.15
3.9
3.7
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
9
30
3.00
2.14
1.0
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
43
274
1.58
2.14
1.1
1.1
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
51
338
1.52
2.14
1.3
1.2
u/ml
34.3
54.6
—
5
20
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
68
479
1.43
2.11
1.5
1.4
u/ml
104.0
117.5
0.41
11
97
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
57
388
1.48
2.11
1.0
1.1
g/l
1.6
1.5
0.64
52
345
(3044927) Protein electrophoresis panel - Urine
48
315
1.53
2.11
1.3
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
38
236
1.62
2.10
2.3
2.0
%
10.4
11.2
0.59
38
236
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
30
175
1.72
2.09
1.6
1.4
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
166
1337
1.25
2.09
3.5
2.5
%
0.6
0.7
0.29
160
1278
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
45
292
1.55
2.08
2.3
2.8
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
46
300
1.54
2.08
3.3
3.9
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
67
474
1.42
2.04
1.4
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
139
1101
1.27
2.02
3.0
3.4
u/ml
2218.5
4611.4
0.37
121
931
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
37
231
1.61
2.02
1.1
1.0
mg/l
294.7
288.0
0.19
32
204
(3048929) Epstein Barr virus Ab [Presence] in Serum
96
723
1.34
2.01
1.2
1.2
—
—
—
0
0
(3036489) Thrombin time
133
1049
1.28
2.00
2.4
2.0
s
21.8
21.6
0.20
126
923
(3042631) Mycobacterium sp identified in Specimen
58
402
1.45
1.98
2.5
2.8
—
—
—
0
0
(1002224) Polysomnography panel
139
1105
1.27
1.97
1.1
1.1
—
—
—
0
0
(4146454)
49
329
1.50
1.96
3.5
2.7
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
5
11
4.55
1.94
1.0
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
19
347
0.54
1.93
2.9
2.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
74
541
1.38
1.89
1.5
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
790
7271
1.11
1.89
4.3
4.1
%
21.6
21.7
0.01
335
3474
(3014271) Vancomycin [Susceptibility]
25
143
1.75
1.88
3.6
2.9
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
47
316
1.49
1.88
1.1
1.1
u/ml
7.9
1.8
—
10
80
(3047181) Lactate [Moles/volume] in Blood
117
918
1.28
1.85
6.3
6.6
mmol/l
1.4
1.3
0.20
111
808
(3035285) Chloride [Moles/volume] in Venous blood
20
355
0.56
1.85
2.8
2.4
mmol/l
106.7
105.2
0.84
20
349
(3041354) Potassium [Moles/volume] in Venous blood
20
355
0.56
1.85
2.8
2.4
mmol/l
4.1
4.1
0.01
20
349
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
17
86
1.98
1.84
1.9
2.0
%
31.5
28.5
0.26
17
78
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
17
86
1.98
1.84
1.8
1.6
ug/l
0.5
0.4
—
10
51
(3002619) Bacteria identified in Specimen by Culture
13
59
2.21
1.84
1.2
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
71
519
1.38
1.83
1.2
1.2
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
5
12
4.17
1.82
1.2
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
34
214
1.59
1.82
1.4
1.4
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
45
303
1.49
1.80
1.3
1.2
u/l
51.8
55.6
0.25
30
207
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
7
23
3.05
1.80
1.1
1.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
39
584
0.66
1.80
1.6
1.7
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
26
153
1.70
1.79
1.1
1.1
—
—
—
0
0
(44813793)
29
176
1.65
1.79
1.0
1.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
8
29
2.76
1.79
1.1
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
53
370
1.44
1.77
1.1
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
69
505
1.37
1.77
1.4
1.6
—
—
—
0
0
(3017704) Immunofixation for Urine
29
177
1.64
1.76
2.3
1.6
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
10
41
2.44
1.75
1.4
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
9
36
2.50
1.74
1.2
1.0
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
58
415
1.40
1.71
1.3
1.2
u/ml
3.3
5.1
0.95
28
175
(21494434) Karyotype in Bone marrow
40
266
1.51
1.71
1.3
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
45
307
1.47
1.70
1.1
1.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
16
82
1.96
1.69
1.7
1.9
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
53
374
1.42
1.69
1.8
1.4
mu/l
62.1
50.3
0.17
47
333
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
50
349
1.44
1.69
1.1
1.1
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
165
1366
1.22
1.67
3.4
2.5
%
1.5
1.2
1.82
165
1354
(3021387) Prolactin [Units/volume] in Serum or Plasma
84
641
1.32
1.66
1.6
1.7
mu/l
321.4
289.6
0.24
72
590
(3028433) Virus identified in Specimen by Culture
18
97
1.86
1.66
1.3
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
66
486
1.37
1.65
1.1
1.2
u/ml
273.7
282.5
0.09
46
292
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
442
3965
1.13
1.65
1.5
1.4
—
—
—
0
0
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
5
14
3.58
1.61
2.4
1.3
mg/l
0.3
0.9
—
5
6
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
5
14
3.58
1.61
2.4
1.3
mg/l
0.5
3.9
—
5
7
(3027570) Oxalate [Moles/time] in 24 hour Urine
5
14
3.58
1.61
2.6
1.4
umol/24h
440.0
364.9
—
5
14
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
5
14
3.58
1.61
2.4
1.3
mg/l
3.3
1.7
—
5
6
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
51
361
1.42
1.61
1.6
1.5
%
57.3
59.2
0.13
37
226
(3045142) Bone marrow Pathology biopsy report
49
345
1.43
1.59
1.3
1.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
147
1211
1.22
1.57
1.9
1.9
u/l
41.5
38.9
0.81
130
1078
(3022493) Free Hemoglobin [Mass/volume] in Plasma
19
107
1.78
1.54
1.3
6.7
mg/l
126.9
65.3
0.41
14
76
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
28
176
1.60
1.54
1.0
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
8
33
2.43
1.53
1.4
1.6
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
66
493
1.35
1.53
3.2
3.4
%
1.0
1.4
0.59
54
383
(3027974) Hepatitis B virus e Ag [Presence] in Serum
5
15
3.34
1.52
1.4
1.6
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
27
169
1.60
1.51
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
27
169
1.60
1.51
1.0
1.0
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
7
27
2.60
1.51
1.3
1.4
—
—
—
0
0
(3019174) dRVVT (LA screen)
7
27
2.60
1.51
1.1
1.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
121
1483
0.81
1.51
2.6
2.8
e6/l
0.3
0.3
0.11
113
1442
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
21
123
1.71
1.50
2.3
2.3
umol/l
57.1
54.5
0.14
16
97
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
210
2439
0.85
1.48
3.7
4.1
mmol/l
1.2
1.2
0.05
185
2131
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
35
235
1.49
1.46
2.2
1.7
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
16
87
1.84
1.45
1.1
1.4
umol/l
2.9
3.6
0.42
16
79
(3050794) Legionella sp Ab [Presence] in Serum
7
28
2.50
1.45
1.1
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
23
140
1.65
1.44
1.3
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
23
140
1.65
1.44
1.3
1.6
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
6
22
2.73
1.43
1.0
1.0
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
41
286
1.44
1.43
1.4
1.3
e6/l
12741.0
96492.6
1.44
28
200
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
9
39
2.31
1.43
1.4
1.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
2403
23444
1.09
1.43
26.6
19.0
g/l
331.7
332.2
1.74
2386
23276
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
29
188
1.55
1.42
2.2
1.5
u/l
2.6
6.7
1.59
18
89
(4268621)
40
278
1.44
1.42
2.3
2.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
57
422
1.36
1.42
1.2
1.2
u/ml
1.7
3.9
1.44
19
137
(3008152) Bicarbonate [Moles/volume] in Arterial blood
217
1876
1.17
1.40
7.8
7.0
mmol/l
24.6
24.6
0.00
209
1752
(3008898) HLA-B27 [Presence]
105
847
1.25
1.39
1.1
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
24
150
1.60
1.37
1.9
1.7
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
16
89
1.80
1.37
1.6
1.7
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
9
41
2.20
1.37
1.1
2.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
6
23
2.61
1.36
1.2
1.0
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
5
17
2.94
1.36
1.4
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
57
426
1.34
1.35
1.8
2.1
u/l
3460.6
3877.4
0.07
15
162
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
48
350
1.38
1.33
1.2
1.4
pmol/l
289.3
285.0
0.04
35
272
(3036071) Salmonella sp Ab [Titer] in Serum
16
90
1.78
1.33
1.1
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
22
136
1.62
1.32
4.6
12.0
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
40
283
1.42
1.31
1.4
1.3
nmol/l
1.2
1.5
0.67
32
254
(3004119) Hemoglobin [Mass/volume] in Venous blood
205
1775
1.16
1.31
3.8
3.0
g/l
127.8
128.5
0.17
200
1730
(21494814) CD8 cells/100 lymphocytes in Specimen
20
121
1.66
1.30
1.9
2.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
102
828
1.24
1.30
1.4
1.4
iu/l
30.2
32.7
0.39
87
704
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
18
106
1.70
1.29
2.9
2.3
%
135.8
165.3
0.98
18
100
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
22
137
1.61
1.29
2.3
2.4
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
23
145
1.59
1.28
1.1
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
42
302
1.40
1.27
1.4
1.4
e6/l
67597.9
86102.6
0.11
25
179
(3035320) C reactive protein [Mass/volume] in Body fluid
29
194
1.50
1.26
3.2
2.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
326
2924
1.13
1.26
1.8
1.6
—
—
—
0
0
(44790049)
46
337
1.37
1.25
2.0
1.5
—
—
—
0
0
(44790048)
46
337
1.37
1.25
2.0
1.5
—
—
—
0
0
(44806118)
46
337
1.37
1.25
2.0
1.5
—
—
—
0
0
(44790047)
46
337
1.37
1.25
2.0
1.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
28
187
1.50
1.23
1.3
1.8
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
32
220
1.46
1.23
1.3
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
25
163
1.54
1.23
1.1
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
15
85
1.77
1.23
1.5
2.2
—
—
—
0
0
(4094501)
103
845
1.23
1.21
1.1
1.1
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
23
148
1.56
1.20
8.9
12.5
nmol/l
719.8
837.7
0.53
23
141
(3044009) aPTT.lupus sensitive (LA screen)
6
26
2.31
1.18
1.2
1.2
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
8
38
2.11
1.18
1.4
1.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
63
489
1.29
1.18
1.8
1.2
u/l
38.2
34.2
0.11
51
427
(3026692) Albumin [Mass/volume] in Peritoneal fluid
14
79
1.78
1.16
1.0
1.5
g/l
12.1
12.9
—
7
59
(3032743) Legionella sp IgG Ab [Presence] in Serum
5
20
2.50
1.15
1.0
1.1
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
5
20
2.50
1.15
1.0
1.1
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
5
20
2.50
1.15
1.2
1.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
27
183
1.48
1.13
1.4
1.3
mmol/l
12.7
11.9
0.18
16
64
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1002
10526
0.93
1.12
4.0
4.0
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
110
918
1.20
1.11
4.7
4.1
mmol/l
3.8
3.9
0.53
104
866
(3016228) CD19 cells/100 cells in Blood
20
127
1.58
1.11
2.0
2.0
%
7.3
8.8
0.32
20
121
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
44
328
1.35
1.10
1.9
1.7
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
79
638
1.24
1.09
2.2
2.2
g/l
127.2
128.7
0.16
42
461
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
36
260
1.39
1.09
3.6
5.0
u/ml
70.4
54.5
—
8
70
(3010421) pH of Blood
64
806
0.79
1.09
4.9
4.5
ph
7.4
7.4
0.24
57
667
(3006653) Thiamine [Moles/volume] in Blood
23
152
1.52
1.08
1.1
1.2
nmol/l
138.7
139.6
0.02
23
152
(3004451) EKG impression Narrative
9
163
0.55
1.08
1.2
1.3
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
32
2.19
1.08
1.1
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
644
6031
1.08
1.07
4.5
4.2
kg/l
1.0
1.0
0.48
89
891
(3008116) Ketones [Moles/volume] in Urine by Test strip
11
59
1.87
1.07
1.5
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
209
2358
0.88
1.05
3.8
4.2
%
0.1
0.1
0.03
74
663
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
29
203
1.43
1.05
1.0
1.3
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
14
82
1.71
1.05
1.1
1.5
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
7
34
2.06
1.02
1.3
1.4
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
7
34
2.06
1.02
1.3
1.4
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
7
34
2.06
1.02
1.3
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
2358
23104
1.07
1.02
24.2
17.9
%
13.8
13.7
3.19
2326
22574
(3023199) Leukocytes [#/volume] in Pleural fluid
45
342
1.32
1.01
1.5
1.4
e6/l
2913.3
2134.2
0.29
31
248
(3025159) Blasts/100 leukocytes in Blood
197
2223
0.88
1.00
3.9
4.2
%
0.1
0.4
0.86
63
561
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
9
48
1.88
1.00
1.8
1.4
ng/l
90.4
111.9
—
9
48
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
7
37
1.89
0.94
1.0
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
48
373
1.29
0.94
1.1
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
44
338
1.31
0.93
1.1
1.1
u/ml
2.4
3.2
—
10
138
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
6
27
2.22
0.93
5.7
4.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
8
145
0.55
0.92
1.5
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
65
526
1.24
0.92
1.8
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
38
287
1.33
0.91
1.5
1.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
16
102
1.57
0.90
1.2
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
52
652
0.79
0.89
4.7
4.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
6
29
2.07
0.89
1.0
1.9
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
204
2276
0.89
0.89
3.8
3.9
%
0.5
0.6
0.49
59
514
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
6
30
2.00
0.87
1.3
1.9
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
44
1.82
0.85
1.0
1.1
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
17
112
1.52
0.84
1.6
2.4
e6/l
444.3
745.5
0.66
12
83
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
48
602
0.79
0.84
1.5
1.8
nmol/l
0.8
0.8
0.05
36
504
(3019977) pH of Arterial blood
22
154
1.43
0.83
2.4
2.8
ph
7.3
7.4
—
6
55
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
8
140
0.57
0.82
1.6
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
36
275
1.31
0.82
1.5
1.5
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
6
32
1.88
0.81
1.5
1.3
umol/l
40.3
44.3
—
6
32
(3032773) Endomysium IgG Ab [Titer] in Serum
28
207
1.36
0.79
1.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
20
139
1.44
0.79
1.4
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
9
147
0.61
0.79
2.2
2.3
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
8
48
1.67
0.78
1.1
1.5
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
29
216
1.35
0.78
1.1
1.1
u/ml
0.1
0.4
—
8
53
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
15
98
1.53
0.78
1.4
2.2
e6/l
578.0
21629.6
—
7
54
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
34
260
1.31
0.78
1.3
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
20
140
1.43
0.76
1.2
1.0
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
134
1181
1.14
0.76
2.1
2.0
ug/l
1.0
1.9
1.98
109
1054
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
6
34
1.77
0.76
1.3
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
35
270
1.30
0.76
2.5
2.4
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
9
53
1.70
0.75
1.2
1.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
11
67
1.64
0.75
1.0
1.2
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
5
24
2.08
0.74
1.0
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
35
271
1.29
0.74
1.7
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
35
271
1.29
0.74
1.7
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
35
271
1.29
0.74
1.7
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
86
737
1.17
0.72
1.4
1.5
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
14
92
1.52
0.72
2.4
5.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
10
60
1.67
0.72
1.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
11
68
1.62
0.71
1.1
1.8
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
35
273
1.29
0.71
1.5
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
52
630
0.82
0.70
2.8
2.6
%
16.1
16.2
0.03
23
314
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
5
27
1.85
0.68
1.4
1.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
42
1.67
0.68
3.4
4.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
81
695
1.17
0.68
1.4
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
33
419
0.79
0.67
1.6
1.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
46
374
1.23
0.67
1.1
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
82
705
1.17
0.67
1.4
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
131
1469
0.89
0.67
1.5
1.5
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
21
153
1.37
0.67
1.1
1.4
nmol/l
1.8
1.3
0.68
15
116
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
79
678
1.17
0.67
1.2
1.1
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
7
43
1.63
0.66
1.0
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
48
393
1.22
0.66
1.2
1.3
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
14
94
1.49
0.66
1.5
2.1
—
—
—
0
0
(4281824)
24
317
0.76
0.66
1.3
1.2
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
5
28
1.79
0.66
1.2
2.8
u/field
0.6
0.6
—
5
28
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
11
70
1.57
0.65
5.7
7.0
%
66.0
71.5
0.28
11
57
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
5
29
1.73
0.64
2.2
1.8
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
8
129
0.62
0.63
1.1
1.2
—
70.5
—
0
15
(42529582) MDA5 Ab [Presence] in Serum by Line blot
12
79
1.52
0.62
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
12
79
1.52
0.62
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
12
79
1.52
0.62
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
12
79
1.52
0.62
1.0
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
11
71
1.55
0.62
1.3
1.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
229
2481
0.92
0.62
3.9
4.2
%
0.7
0.9
1.28
81
716
(3020876) Protein [Mass/time] in 24 hour Urine
32
253
1.27
0.61
1.7
1.9
—
1.8
—
0
11
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
34
271
1.26
0.61
1.4
1.5
nmol/l
0.3
0.3
0.25
22
200
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
17
122
1.40
0.60
1.4
1.5
umol/l
30.8
29.1
0.35
17
116
(3029937) Albumin [Presence] in Urine by Test strip
715
7441
0.95
0.59
4.3
4.2
estimate
0.0
0.0
1.28
199
2483
(3042111) Morphology [Interpretation] in Bone marrow Narrative
61
519
1.18
0.59
1.9
1.6
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
0
23
0.00
0.58
0.0
1.6
—
19.6
—
0
14
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
8
53
1.51
0.58
1.3
1.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
19
140
1.36
0.58
3.8
3.5
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
24
184
1.31
0.57
1.6
1.2
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
6
35
1.72
0.57
1.2
1.2
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
6
35
1.72
0.57
1.2
1.3
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
20
149
1.34
0.57
2.0
1.6
u/field
0.9
3.4
—
10
111
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
21
158
1.33
0.57
1.1
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
79
689
1.15
0.57
1.4
1.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
208
2252
0.92
0.57
1.8
1.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
44
365
1.21
0.56
1.3
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
8
55
1.46
0.56
1.1
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
83
728
1.14
0.56
2.2
1.6
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
6
37
1.62
0.55
1.0
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
10
65
1.54
0.55
1.5
2.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
58
677
0.85
0.55
5.1
4.8
mmol/l
2.4
2.7
0.34
34
476
(3003694) ABO and Rh group [Type] in Blood
768
7406
1.05
0.54
1.4
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
82
1.47
0.54
1.2
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
9
60
1.50
0.54
2.4
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
135
1484
0.91
0.52
3.4
3.4
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
31
250
1.24
0.52
1.1
1.1
u/ml
3.2
3.3
0.01
14
97
(3001186) Copper [Moles/volume] in Serum or Plasma
9
65
1.39
0.50
1.3
1.2
umol/l
19.2
16.8
—
9
60
(3014891) Appearance of Pleural fluid
6
41
1.46
0.50
1.3
1.8
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
48
563
0.85
0.50
1.1
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
22
280
0.78
0.50
1.8
1.5
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
65
744
0.87
0.50
2.9
3.2
mmol/l
24.6
25.0
0.36
53
648
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
10
67
1.49
0.49
1.4
2.2
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
30
243
1.24
0.49
1.9
1.8
mg/l
5.0
4.3
0.19
30
236
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
12
84
1.43
0.49
2.8
2.7
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
12
84
1.43
0.49
2.8
2.7
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
33
271
1.22
0.48
1.1
1.1
u/ml
4.9
2.7
0.24
15
104
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
7
110
0.64
0.48
1.1
1.6
%
50.4
62.0
—
7
87
(3024932) HLA-DR beta [Type]
13
93
1.40
0.48
1.1
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
15
200
0.75
0.47
1.5
1.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
14
102
1.37
0.47
1.1
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
19
244
0.78
0.47
2.8
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
586
6086
0.96
0.46
5.6
4.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
80
712
1.13
0.46
2.2
1.6
—
—
—
0
0
(44806420)
5
83
0.60
0.45
3.0
2.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
37
310
1.20
0.45
2.1
1.7
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
50
1.40
0.45
1.3
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
43
366
1.18
0.45
1.3
1.3
nmol/l
—
—
—
0
0
(3024471) HLA-A [Type]
13
95
1.37
0.43
1.0
1.0
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
11
78
1.41
0.43
4.0
2.5
%
162.0
178.3
0.18
11
72
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
14
104
1.35
0.43
2.4
2.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
5
31
1.61
0.43
2.2
3.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
210
1968
1.07
0.42
1.4
1.3
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
119
1298
0.91
0.42
4.2
3.7
%
52.1
49.1
0.67
119
1279
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
21
262
0.80
0.42
1.1
1.1
—
—
—
0
0
(44806071)
5
32
1.56
0.42
1.0
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
18
140
1.29
0.42
1.0
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
20
158
1.27
0.41
2.0
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
20
158
1.27
0.41
2.0
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
20
158
1.27
0.41
2.0
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
20
158
1.27
0.41
2.0
1.8
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
10
70
1.43
0.41
4.9
7.8
—
—
—
0
0
(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.2
—
1.0
—
0
8
(3038177) Helicobacter pylori Ab [Presence] in Serum
47
407
1.16
0.41
1.3
1.3
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
26
315
0.82
0.40
5.0
5.4
mmol/l
7.1
7.3
0.08
18
265
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
17
0.00
0.40
0.0
1.3
—
4996.0
—
0
10
(21491868) Cryoglobulin [Mass/volume] in Serum
15
114
1.32
0.40
1.0
1.2
g/l
—
0.3
—
0
10
(3023511) Choriogonadotropin [Units/volume] in Urine
25
204
1.23
0.40
1.2
1.2
—
—
—
0
0
(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.3
—
14.3
—
0
11
(3036525) Urea [Moles/time] in 24 hour Urine
0
18
0.00
0.40
0.0
3.6
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
5
35
1.43
0.39
2.6
2.3
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
0
19
0.00
0.39
0.0
1.3
—
40.2
—
0
11
(1617658) Protocol used for examination of sentinel lymph nodes
20
248
0.81
0.39
1.1
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
18
142
1.27
0.38
2.0
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
13
170
0.76
0.38
1.7
1.7
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
9
67
1.34
0.38
1.9
3.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
48
420
1.14
0.37
1.9
1.5
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
6
42
1.43
0.35
8.3
14.8
mmol/l
4.7
5.6
—
6
42
(3044290) Cell count panel - Cerebral spinal fluid
64
574
1.12
0.35
1.4
1.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
9
125
0.72
0.35
1.3
1.2
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
35
405
0.86
0.34
2.0
1.9
%
89.0
89.6
0.31
35
399
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
22
181
1.22
0.34
1.6
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
34
293
1.16
0.33
1.4
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
60
539
1.12
0.33
2.4
1.7
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
6
46
1.30
0.33
1.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
86
0.70
0.33
1.0
1.1
—
—
—
0
0
(4034850)
89
968
0.92
0.32
13.6
9.8
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
6
90
0.67
0.32
1.0
1.0
—
6.2
—
0
13
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
6
47
1.28
0.32
1.2
1.2
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
18
146
1.23
0.32
1.8
2.5
mmol/l
8.7
9.6
0.44
11
114
(3003434) Protein [Mass/volume] in Pleural fluid
43
379
1.14
0.32
1.4
1.5
g/l
32.3
32.5
0.05
38
338
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
48
539
0.89
0.32
2.3
3.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
12
92
1.31
0.31
1.3
1.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
56
621
0.90
0.30
4.8
3.6
mg/l
32.3
27.7
0.28
30
382
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
78
850
0.92
0.30
1.7
1.8
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
25
212
1.18
0.30
1.2
1.5
pmol/l
68.7
202.8
0.45
12
65
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
38
431
0.88
0.30
1.5
1.6
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
14
111
1.26
0.30
1.1
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
15
185
0.81
0.29
1.1
1.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
20
167
1.20
0.28
1.6
1.7
—
—
—
0
0
(3020891) Body temperature
130
1223
1.07
0.27
5.7
4.5
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
8
64
1.25
0.27
5.5
8.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
204
0.83
0.27
2.7
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
48
531
0.90
0.26
2.6
2.9
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
10
77
1.30
0.26
1.8
1.7
mmol/l
-0.2
1.4
—
10
72
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
46
415
1.11
0.25
1.2
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
9
73
1.23
0.25
1.2
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
41
456
0.90
0.25
1.1
1.1
iu/ml
49.8
77.4
—
10
101
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
31
273
1.14
0.25
1.8
1.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
13
105
1.24
0.24
1.1
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
11
87
1.27
0.24
2.5
1.8
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
81
0.74
0.24
1.2
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
295
3049
0.96
0.23
3.9
3.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
115
1216
0.94
0.23
1.7
1.7
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
5
40
1.25
0.22
1.6
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
18
153
1.18
0.22
1.1
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
10
124
0.81
0.21
1.6
1.5
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3007700) Barley IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
0.1
—
0
5
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016031) Almond IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
0.1
—
0
5
(3018001) Oat IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
0.3
—
0
5
(43055442) Apixaban [Mass/volume] in Serum or Plasma
5
43
1.16
0.21
1.4
1.4
ug/l
94.6
145.7
—
5
38
(3013762) Body weight Measured
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
13
0.00
0.21
0.0
6.0
—
406.5
—
0
13
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
30
335
0.89
0.21
1.2
1.3
mmol/l
7.4
7.5
0.04
20
245
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
6
48
1.25
0.20
1.2
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
9
111
0.81
0.20
3.7
2.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
6
50
1.20
0.19
2.0
1.4
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
6
50
1.20
0.19
6.5
7.2
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
24
212
1.13
0.19
2.1
1.9
mmol/l
7.8
6.9
0.52
16
133
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
16
186
0.86
0.19
6.4
6.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
7
58
1.21
0.18
1.4
1.3
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
7
59
1.19
0.18
1.1
2.9
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
11
91
1.21
0.17
1.2
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
66
0.76
0.17
2.6
2.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
9
78
1.15
0.15
1.2
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
82
1.10
0.15
1.2
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
15
171
0.88
0.14
1.5
1.4
—
1.5
—
0
9
(40761539) Cells [Type] in Urine sediment by Light microscopy
9
83
1.08
0.14
1.3
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
7
87
0.80
0.14
1.1
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
31
285
1.09
0.14
1.6
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
49
460
1.07
0.14
1.9
1.5
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
8
99
0.81
0.13
1.1
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
33
305
1.08
0.13
1.1
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
75
715
1.05
0.13
1.3
1.2
mg/l
534.1
531.9
0.01
70
675
(4306422)
44
412
1.07
0.13
1.3
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
55
582
0.94
0.13
4.1
3.6
%
57.4
57.3
0.02
55
582
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
43
404
1.07
0.12
2.0
1.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
43
457
0.94
0.12
1.1
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
36
336
1.07
0.12
2.7
1.7
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
42
396
1.06
0.11
1.2
1.1
—
9.9
—
0
20
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
75
720
1.04
0.11
2.0
2.4
ug/min
170.3
112.7
0.26
45
445
(3047352) Trisomy 18 risk [Likelihood] in Fetus
17
188
0.90
0.11
1.4
1.4
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
10
86
1.16
0.11
1.2
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
15
134
1.12
0.11
3.0
4.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
16
177
0.90
0.10
2.8
1.7
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
17
187
0.91
0.10
1.4
1.4
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
5
44
1.14
0.10
1.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
45
1.11
0.09
3.0
1.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
5
64
0.78
0.08
1.4
2.5
ml/dl
18.0
14.9
—
5
59
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
5
64
0.78
0.08
1.8
1.8
mmol/l
1.2
1.2
—
5
64
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
65
0.77
0.08
1.2
1.3
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
5
65
0.77
0.08
1.2
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
27
286
0.94
0.07
1.3
2.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
9
84
1.07
0.07
1.2
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
9
84
1.07
0.07
1.4
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
14
128
1.09
0.06
2.4
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
14
128
1.09
0.06
2.4
1.9
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
142
1395
1.02
0.06
3.7
3.3
mmol/l
25.4
25.3
0.09
137
1349
(3035880) pH of Pleural fluid
15
162
0.93
0.06
1.3
1.4
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
65
633
1.03
0.05
1.2
1.2
mmol/l
3.9
3.8
0.24
60
596
(3044242) Glucose [Moles/volume] in Arterial blood
14
151
0.93
0.05
2.1
2.2
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
27
283
0.95
0.05
3.6
2.9
mg/l
24.6
32.5
0.19
19
210
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
22
232
0.95
0.05
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
22
232
0.95
0.05
1.4
1.4
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
12
110
1.09
0.05
1.6
1.6
umol/l
1.9
2.0
0.05
12
101
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
14
130
1.08
0.04
2.4
1.9
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
49
476
1.03
0.04
1.9
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
80
816
0.98
0.04
1.2
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
22
231
0.95
0.04
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
22
231
0.95
0.04
1.4
1.4
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
15
159
0.94
0.03
1.1
1.2
ratio
1.1
1.1
—
6
52
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
92
933
0.99
0.03
1.6
1.7
mg/l
2.7
4.0
0.82
70
673
(40768446) Kidney Pathology biopsy report
12
112
1.07
0.03
1.3
1.6
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
61
621
0.98
0.02
1.4
1.4
e6/l
990.3
1144.1
0.08
48
510
(40768795) Lymph node Pathology biopsy report
28
289
0.97
0.02
1.1
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
17
178
0.95
0.02
1.2
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
61
620
0.98
0.02
1.4
1.3
e6/l
45.6
27.3
0.19
47
484
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
11
103
1.07
0.02
1.4
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
17
177
0.96
0.01
2.6
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
43
423
1.02
0.01
2.3
1.6
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
12
114
1.05
0.00
1.7
2.0
ug/l
30.8
87.5
0.37
12
100
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
23
228
1.01
0.00
1.9
2.1
u/field
2.0
1.9
—
10
93
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
22
225
0.98
0.00
1.0
1.0
ng/l
39.2
46.6
0.42
17
140
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
24
245
0.98
0.00
1.5
1.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
11
111
0.99
0.00
1.2
1.0
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
29
291
1.00
0.00
1.5
1.4
%
31.7
32.0
0.02
19
180
(3028626) Oxygen [Partial pressure] in Capillary blood
63
629
1.00
0.00
2.5
3.1
kpa
7.9
8.1
0.32
55
575
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
11
114
0.96
0.00
1.1
1.1
iu/ml
128.5
190.5
0.97
11
114
(4027681)
14
144
0.97
0.00
1.4
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
19
194
0.98
0.00
1.4
1.5
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
10
103
0.97
0.00
1.3
1.1
miu/ml
1660.5
1591.8
—
10
103
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
22
223
0.99
0.00
1.0
1.0
ng/l
813.4
715.1
0.41
17
140
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
493.1
—
0
7
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
7
78
0.90
0.00
2.9
1.8
mg/l
8.5
9.4
—
7
64
(3002568) Complement factor B [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
0.2
—
0
6
(3011325) HIV 1+2 Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
1.8
—
0
7
(3006598) pH of Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016135) IgD [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
119.9
—
0
7
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
6
0.00
0.00
0.0
5.2
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
6
61
0.98
0.00
2.3
1.5
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
9
92
0.98
0.00
1.2
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
92
0.98
0.00
1.2
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
7
76
0.92
0.00
1.3
1.6
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
86
0.93
0.00
1.1
1.1
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
57
0.88
0.00
1.6
1.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
19
190
1.00
0.00
1.4
1.2
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(4133840)
7
72
0.97
0.00
1.0
1.2
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
2.4
—
0
5
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
6
59
1.02
0.00
1.3
1.2
—
139.8
—
0
9
(3002719) Hemoglobin [Mass/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
1308.0
—
0
5
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
7
70
1.00
0.00
1.3
1.4
%
26.3
23.8
—
7
55
(3018291) Platelet Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
8
0.00
0.00
0.0
1.7
—
—
—
0
0
(4038314)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
7
70
1.00
0.00
1.1
1.1
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
7.8
—
0
5

Mortality – FinRegistry

Association

Association between endpoint K11_ORAL_LEUCOPLAC_RELAT_INCLAVO and mortality.

Females

Parameter HR [95% CI] p-value
K11_ORAL_LEUCOPLAC_RELAT_INCLAVO 1.181 [1.06, 1.31] 0.002
Birth year 0.989 [0.98, 1.0] 0.021

During the follow-up period (1.1.1998 — 31.12.2019), 1320 out of 8669 females with K11_ORAL_LEUCOPLAC_RELAT_INCLAVO died.

Males

Parameter HR [95% CI] p-value
K11_ORAL_LEUCOPLAC_RELAT_INCLAVO 1.233 [1.1, 1.38] < 0.001
Birth year 0.986 [0.98, 0.99] 0.003

During the follow-up period (1.1.1998 — 31.12.2019), 1182 out of 6913 males with K11_ORAL_LEUCOPLAC_RELAT_INCLAVO died.

Mortality risk

Mortality risk for people of age

years, who have K11_ORAL_LEUCOPLAC_RELAT_INCLAVO.

N-year risk Females Males
1 0.103% 0.195%
5 0.575% 1.367%
10 1.485% 3.489%
15 2.861% 6.609%
20 4.837% 11.179%

Relationships between endpoints

Index endpoint: K11_ORAL_LEUCOPLAC_RELAT_INCLAVO – Oral leukoplakia and related diseases, including avohilmo

GWS hits: 2

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data